Original Article
Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
N Engl J Med 2006; 354:934-941March 2, 2006
- Abstract
Background
We conducted a randomized, controlled trial of circumferential pulmonary-vein ablation for the treatment of chronic atrial fibrillation.
Methods
A total of 146 patients with a mean (±SD) age of 57±9 years who had chronic atrial fibrillation were randomly assigned to receive amiodarone and undergo two cardioversions during the first three months alone (the control group) or in combination with circumferential pulmonary-vein ablation. Cardiac rhythm was assessed with daily telephonic transmissions for one year. The left atrial diameter and the severity of symptoms were assessed at 12 months.
Results
Among the 77 patients assigned to undergo circumferential pulmonary-vein ablation, ablation was repeated because of recurrent atrial fibrillation in 26 percent of patients and atypical atrial flutter in 6 percent. An intention-to-treat analysis showed that 74 percent of patients in the ablation group and 58 percent of those in the control group were free of recurrent atrial fibrillation or flutter without antiarrhythmic-drug therapy at one year (P=0.05). Among the 69 patients in the control group, 53 (77 percent) crossed over to undergo circumferential pulmonary-vein ablation for recurrent atrial fibrillation by one year and only 3 (4 percent) were in sinus rhythm without antiarrhythmic-drug therapy or ablation. There were significant decreases in the left atrial diameter (12±11 percent, P<0.001) and the symptom severity score (59±21 percent, P<0.001) among patients who remained in sinus rhythm after circumferential pulmonary-vein ablation. Except for atypical atrial flutter, there were no complications attributable to circumferential pulmonary-vein ablation.
Conclusions
Sinus rhythm can be maintained long term in the majority of patients with chronic atrial fibrillation by means of circumferential pulmonary-vein ablation independently of the effects of antiarrhythmic-drug therapy, cardioversion, or both. The maintenance of sinus rhythm is associated with a significant decrease in both the severity of symptoms and the left atrial diameter.
Media in This Article
Figure 1
Study Design and Results.Figure 2
Circumferential Pulmonary-Vein Ablation.Article Activity
- Article
Circumferential pulmonary-vein ablation is reported to be effective for paroxysmal and chronic atrial fibrillation.1-5 However, patients with chronic atrial fibrillation typically receive temporary antiarrhythmic-drug therapy after ablation and often require one or more cardioversions to restore sinus rhythm. These are confounding variables that may inflate the efficacy of catheter ablation. Furthermore, prior studies have not systematically monitored patients for asymptomatic recurrences of atrial fibrillation on a frequent basis. Therefore, we conducted a randomized, controlled study to determine the long-term efficacy of circumferential pulmonary-vein ablation in patients with chronic atrial fibrillation while taking into account the confounding variables of antiarrhythmic-drug therapy and cardioversion.
Methods
Study Population
Between November 2002 and February 2004, 146 patients with chronic atrial fibrillation were randomly assigned to receive amiodarone and undergo two cardioversions during the first three months alone (the control group) or in combination with circumferential pulmonary-vein ablation. Chronic atrial fibrillation was defined as atrial fibrillation that had been present for more than six months without intervening spontaneous episodes of sinus rhythm and that recurred within one week after cardioversion. Exclusion criteria are listed in Table 1Table 1
Exclusion Criteria.. The clinical characteristics of the two groups of patients are described in Table 2Table 2
Characteristics of the Patients..Study Design
The study was designed to determine the efficacy of circumferential pulmonary-vein ablation in maintaining sinus rhythm in the absence of antiarrhythmic-drug therapy in patients with chronic atrial fibrillation. To prevent short-term recurrences of atrial fibrillation that could interfere with the reverse remodeling process, patients received amiodarone for three months after undergoing circumferential pulmonary-vein ablation. In addition, if atrial fibrillation recurred within the first three months after ablation and persisted, cardioversion was performed. Because the combination of short-term treatment with amiodarone and cardioversion may result in atrial remodeling that promotes long-term sinus rhythm even after treatment with amiodarone is discontinued, patients in the control group also received amiodarone for three months and underwent cardioversion. The study design and flow are presented in Figure 1Figure 1
Study Design and Results..Study Protocol
The study was conducted at the San Raffaele Hospital in Milan and the University of Michigan Medical Center in Ann Arbor. The study protocol was approved by the institutional review board at each institution. Written informed consent was obtained from all patients. A computer-generated randomization table was used for randomization.
Patients were seen in the clinic before randomization and at 3, 6, and 12 months. An electrocardiogram and transthoracic echocardiogram were obtained during these visits, and patients completed a questionnaire to assess the severity of symptoms of arrhythmia (maximum possible score, 25, with higher scores indicating more severe disease; details are provided in the Supplementary Appendix, available with the full text of this article at www.nejm.org).
All patients were given an event monitor (LifeWatch) for one year and were asked to record their rhythm at least five days a week for three minutes and whenever they had symptoms suggestive of atrial fibrillation. All rhythm tracings were interpreted in a blinded fashion by two physicians at the University of Michigan who did not otherwise participate in the study. Rhythms were classified as atrial fibrillation, atrial flutter, sinus rhythm, or indeterminate. An arrhythmia had to last more than three seconds to be classified as atrial fibrillation or atrial flutter. Indeterminate rhythms (which represented a mean [±SD] of 1.0±0.8 percent of all transmissions per patient) were reviewed by the investigators, and a consensus was reached. Rhythm transmissions were available in all patients for 85±8 percent of the days of follow-up.
Circumferential Pulmonary-Vein Ablation
Treatment with 200 mg of amiodarone orally per day was initiated six weeks before circumferential pulmonary-vein ablation. A transesophageal echocardiogram was obtained immediately before the procedure to rule out the presence of atrial thrombi. An electrode catheter in the coronary sinus was used to record left atrial electrical activity and for pacing. After transseptal puncture, intravenous heparin was infused to maintain an activated clotting time of at least 300 seconds.
Ablation was guided by an electroanatomical mapping system (CARTO, Biosense Webster) and performed with a temperature-controlled, quadripolar, deflectable catheter with an 8-mm tip (Navistar, Biosense Webster) to encircle the left and right pulmonary veins 1 to 2 cm from their ostia, with additional lines in the posterior left atrium or roof and along the mitral isthmus (Figure 2Figure 2
Circumferential Pulmonary-Vein Ablation.). Contiguous applications of radiofrequency energy were delivered at a target temperature of 55°C and a maximal power output of 70 W for 20 to 40 seconds at each site. The end point of ablation was an 80 percent reduction in the amplitude of the electrogram or a total of 40 seconds of energy application. Additional ablation was performed within the circles, outside the pulmonary veins, where the local electrogram amplitude exceeded 0.2 mV. If atrial fibrillation was still present at the end of circumferential pulmonary-vein ablation, either ibutilide or transthoracic cardioversion was used to restore sinus rhythm (some patients received both treatments).Patients were hospitalized overnight. Heparin was infused and warfarin therapy was started the same day. On discharge, patients received low-molecular-weight heparin until their international normalized ratio was at least 2.0. Patients received 200 mg of amiodarone orally per day for three months. Transthoracic cardioversion was permitted for recurrent atrial fibrillation during the first three months after circumferential pulmonary-vein ablation. When necessary because of recurrent atrial fibrillation, circumferential pulmonary-vein ablation was repeated.
Control Group
Patients in the control group received 200 mg of amiodarone orally per day for at least six weeks after randomization and then underwent transthoracic cardioversion. Amiodarone was discontinued after three months. Patients with recurrent atrial fibrillation were allowed to undergo cardioversion a second time within three months after the first cardioversion. Patients in whom recurrent atrial fibrillation developed more than three months after the first cardioversion were allowed to resume amiodarone therapy or to undergo circumferential pulmonary-vein ablation.
Follow-up
All patients had 12 months of follow-up. In both study groups, warfarin was discontinued at six months if there was no evidence of atrial fibrillation on daily rhythm tracings.
End Points
The primary end point of the study was freedom from atrial fibrillation and atrial flutter in the absence of antiarrhythmic-drug therapy one year after ablation in the group that underwent circumferential pulmonary-vein ablation or one year after cardioversion in the control group. The results were analyzed on an intention-to-treat basis. Because the control group was designed to control for confounding variables and not to compare circumferential pulmonary-vein ablation with a pharmacologic treatment strategy, we also analyzed the data according to the treatment actually received. Secondary end points were the incidence of complications, changes in the diameter of the left atrium and the left ventricular ejection fraction, and changes in the severity of symptoms.
Statistical Analysis
Assuming that sinus rhythm would be present at one year in 70 percent of patients who underwent circumferential pulmonary-vein ablation and 40 percent of patients in the control group, we estimated that a minimum of 56 patients was required in each group to give the study a statistical power of 90 percent with a two-tailed alpha value of 0.05. We determined the prevalences of sinus rhythm, atrial fibrillation, and atrial flutter each month. Even if only one rhythm recording in a given month demonstrated atrial fibrillation or atrial flutter, the patient was classified as having had atrial fibrillation or atrial flutter in that month.
Continuous variables are expressed as means ±SD and were compared with use of Student's t-test. Categorical variables were compared with use of chi-square analysis or Fisher's exact test. All P values were two-sided, and a P value of less than 0.05 was considered to indicate statistical significance.
Results
Circumferential Pulmonary-Vein Ablation
Circumferential pulmonary-vein ablation was performed in 77 patients with the use of a mean of 37±11 minutes of radiofrequency energy. Atrial fibrillation was terminated during circumferential pulmonary-vein ablation in 12 of the 77 patients (16 percent). In the remaining 65 patients, sinus rhythm was restored after the ablation by the administration of ibutilide or transthoracic cardioversion. The mean duration of the procedure was 96±77 minutes. At the discretion of the operator, cavotricuspid isthmus ablation was also performed in 55 patients to prevent typical atrial flutter.
Transthoracic cardioversion was performed in 18 of the 77 patients (23 percent) a mean of 78±45 days after circumferential pulmonary-vein ablation, because of recurrent atrial fibrillation in 14 and atrial flutter in 4. Except for one patient who continued to take amiodarone for recurrent atrial fibrillation, patients discontinued amiodarone therapy a mean of 72±71 days after undergoing circumferential pulmonary-vein ablation. The ablation procedure was repeated in 20 patients (26 percent) because of recurrent atrial fibrillation and in 5 patients (6 percent) because of left atrial flutter, a mean of 204±82 days after the first procedure.
Control Group
After the initiation of treatment with amiodarone, 3 of the 69 patients in the control group converted to sinus rhythm. In the other 66 patients, sinus rhythm was restored by transthoracic cardioversion. Atrial fibrillation recurred within two months in 67 patients (97 percent), and these patients underwent a second cardioversion a mean of 72±25 days after the first cardioversion. Except in 25 patients who elected to resume therapy, amiodarone was discontinued permanently a mean of 135±42 days after the first cardioversion in all patients.
Freedom from Recurrent Atrial Fibrillation and Flutter
According to the intention-to-treat analysis, 12 months after the first circumferential pulmonary-vein ablation, 57 of 77 patients in the group that underwent circumferential pulmonary-vein ablation were in sinus rhythm and free of atrial fibrillation and atrial flutter in the absence of antiarrhythmic-drug therapy (74 percent). At 12 months, atrial fibrillation was present in 22 percent of patients and atrial flutter was present in 4 percent of patients.
According to the intention-to-treat analysis, in the control group, 40 of 69 patients were free of atrial fibrillation 12 months after the first cardioversion in the absence of antiarrhythmic-drug therapy (58 percent, P=0.05 by Fisher's exact test for the comparison with the group that underwent circumferential pulmonary-vein ablation) (Figure 1). Seven patients (10 percent) had resumed treatment with amiodarone and were in sinus rhythm at 12 months of follow-up.
Crossover to Circumferential Pulmonary-Vein Ablation in the Control Group
In the control group, 53 patients (77 percent) with recurrent atrial fibrillation crossed over to undergo circumferential pulmonary-vein ablation a mean of 128±57 days after cardioversion. Sinus rhythm was present in 37 of these 53 patients (70 percent) in the absence of antiarrhythmic-drug therapy at 12 months of follow-up. Only 3 of the 69 patients in the control group were free of recurrent atrial fibrillation 12 months after the first cardioversion in the absence of antiarrhythmic-drug therapy and circumferential pulmonary-vein ablation (4 percent, P<0.001 for the comparison with the group that underwent circumferential pulmonary-vein ablation) (Figure 3Figure 3
Percentages of Patients without Atrial Fibrillation and Atrial Flutter in the Absence of Antiarrhythmic-Drug Therapy.).Left Atrial Flutter
Five of the 77 patients underwent an ablation procedure for atypical atrial flutter at a mean of 139±123 days. The atrial-flutter circuit used the mitral isthmus in two of these patients, gaps along the right or left circles in two patients, and multiple left atrial sites in one patient.
Diameter of the Left Atrium
Among patients without recurrent atrial fibrillation in the group that underwent circumferential pulmonary-vein ablation, the diameter of the left atrium was smaller at 12 months than before the procedure (40±6 mm vs. 45±6 mm, P<0.001). There was no significant difference in the left atrial diameter among patients with recurrent atrial fibrillation.
Left Ventricular Ejection Fraction
Among the patients who remained in sinus rhythm, the left ventricular ejection fraction was higher 12 months after circumferential pulmonary-vein ablation than before the procedure (0.62±0.08 vs. 0.55±0.06, P<0.001). There was no significant difference in the left ventricular ejection fraction values among patients with recurrent atrial fibrillation (P=0.47).
Severity of Symptoms
Among the patients who remained in sinus rhythm, the symptom severity score was 17±4 at baseline and 6±2 points at 12 months after circumferential pulmonary-vein ablation (P<0.001). Among the patients who had recurrent atrial fibrillation or atrial flutter, the symptom severity score was 17±4 at baseline and 12±4 at 12 months after circumferential pulmonary-vein ablation (P=0.02). Patients who were in sinus rhythm had a greater improvement in the symptom severity score than did patients with recurrent atrial fibrillation or atrial flutter (10±5 vs. 5±7, P=0.002).
Complications and Other Events
Other than the atypical flutters in the group that underwent circumferential pulmonary-vein ablation, there were no complications in either group. One patient in the group that underwent circumferential pulmonary-vein ablation and one patient in the control group received a permanent pacemaker for the sick sinus syndrome unrelated to ablation or drug therapy. Another patient in the group that underwent circumferential pulmonary-vein ablation who had recurrent atrial fibrillation underwent atrioventricular-junction ablation and received a pacemaker. A 66-year-old patient with a nonischemic cardiomyopathy died of pneumonia seven months after undergoing circumferential pulmonary-vein ablation.
Discussion
We found that circumferential pulmonary-vein ablation resulted in long-term maintenance of sinus rhythm without the need for antiarrhythmic-drug therapy in 74 percent of patients with chronic atrial fibrillation. Because sinus rhythm was maintained in only 4 percent of patients in the control group in the absence of antiarrhythmic-drug therapy or circumferential pulmonary-vein ablation, the efficacy of ablation cannot be attributed to transient therapy with amiodarone, cardioversion, or both. The maintenance of sinus rhythm after circumferential pulmonary-vein ablation was associated with a decrease in the diameter of the left atrium, an improvement in the left ventricular ejection fraction, and a reduction in the severity of symptoms. Atypical atrial flutter was the only complication attributable to circumferential pulmonary-vein ablation in this study. In addition, the procedure took less than two hours in most patients.
Many prior studies of ablation in patients with atrial fibrillation have been uncontrolled or have not systematically looked for asymptomatic episodes of recurrent atrial fibrillation on a frequent basis. Our study demonstrates that catheter ablation is reasonably efficacious in chronic atrial fibrillation independently of antiarrhythmic-drug therapy and cardioversion and with the use of a rigorous end point involving intense telephonic monitoring during follow-up. However, our study was not designed to demonstrate the superiority of circumferential pulmonary-vein ablation over pharmacologic therapy. Furthermore, we present no evidence that early circumferential pulmonary-vein ablation has any advantage over a deferred procedure.
Circumferential pulmonary-vein ablation may exert its beneficial effects by eliminating “driver tachycardias” or “rotors” that could play a role in the genesis of atrial fibrillation,6,7 autonomic denervation of the left atrium,8 isolation of the pulmonary veins,9 atrial debulking,10 and elimination of arrhythmogenic foci outside the pulmonary veins.11 Recurrent atrial fibrillation and atrial flutter were most common within the first weeks after circumferential pulmonary-vein ablation and were often transient. Early arrhythmias after circumferential pulmonary-vein ablation may be due to proarrhythmic effects of radiofrequency ablation within the left atrium or to residual mechanisms of atrial fibrillation that resolve as a result of maturation and progressive fibrosis of the ablation lesions. Late recurrences of atrial fibrillation may have been due to the emergence of new mechanisms of atrial fibrillation that were not eliminated by circumferential pulmonary-vein ablation, the recovery of conduction at previously ablated sites, or the washout of amiodarone, which was discontinued three months after ablation.
It is consistent with prior reports of the effect of circumferential pulmonary-vein ablation on the diameter of the left atrium4,12 that we found a significant decrease in the diameter in patients who remained in sinus rhythm after ablation. This finding suggests that maintenance of sinus rhythm after circumferential pulmonary-vein ablation resulted in the resumption of atrial transport function and reverse atrial anatomical remodeling.
Patients who remained in sinus rhythm after undergoing circumferential pulmonary-vein ablation also had an improvement in the left ventricular ejection fraction. This improvement may have been due to the elimination of tachycardia-mediated ventricular dysfunction or the resumption of atrioventricular synchrony with regular RR intervals, or to both mechanisms.
As expected, there was a marked decrease in the severity of symptoms in patients who remained in sinus rhythm after they had undergone circumferential pulmonary-vein ablation. Patients with recurrent atrial fibrillation after they had undergone circumferential pulmonary-vein ablation had a smaller improvement. This may have been due to a placebo effect or to a decrease in the burden of atrial fibrillation (i.e., atrial fibrillation may have become less frequent and the episodes may have become shorter after ablation). It is also possible that regular clinic visits resulted in improved control of the ventricular rate during the study.
No complications other than left atrial flutter were attributable to circumferential pulmonary-vein ablation. However, atrioesophageal fistula was recently reported to be a rare complication of catheter ablation in the posterior left atrium.13,14 A reduction in the power output, target temperature, and duration of radiofrequency-energy applications and avoidance of sites on the posterior wall of the left atrium overlying the esophagus should prevent esophageal injury. Real-time, direct visualization of the esophagus may also be helpful.15 The risk of atrioesophageal fistula should be carefully considered when one is selecting an ablation strategy for patients with atrial fibrillation.
Patients with a low left ventricular ejection fraction or a markedly dilated left atrium (more than 55 mm) were excluded from the study. Furthermore, the age cutoff was 70 years. Therefore, our findings are not applicable to all patients with chronic atrial fibrillation.
Many patients in the control group who had recurrent atrial fibrillation resumed therapy with amiodarone or underwent circumferential pulmonary-vein ablation after three months of follow-up. Ideally, outcomes in the two study groups would have been compared during 12 months of follow-up. However, the patients in this study were referred because they had symptoms despite drug therapy, and a requirement for 12 months of follow-up without further intervention despite the presence of recurrent atrial fibrillation would have severely limited our ability to recruit subjects.
We demonstrated that circumferential pulmonary-vein ablation can restore and maintain sinus rhythm in approximately 75 percent of patients with symptomatic, chronic atrial fibrillation, with a concomitant decrease in both the severity of symptoms and the diameter of the left atrium. Therefore, patients with chronic atrial fibrillation who otherwise would be destined to remain in atrial fibrillation for the rest of their lives can be offered the option of radiofrequency catheter ablation, even when chronic atrial fibrillation has been present for several years.
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial demonstrated that the use of a rhythm-control strategy does not have any advantages over the use of a rate-control strategy in patients with atrial fibrillation.16 However, the patients in that trial were elderly (mean age, 70 years) and did not have that many symptoms, and the rhythm-control strategy consisted of antiarrhythmic drugs that had not been very effective and had the potential for serious adverse effects. Therefore, the results of the AFFIRM trial should not be applied to all patients with atrial fibrillation. Our findings demonstrate that circumferential pulmonary-vein ablation is a reasonable option in patients with symptomatic, chronic atrial fibrillation.
Supported by the Ellen and Robert Thompson Atrial Fibrillation Research Fund (Ann Arbor, Mich.).
Drs. Oral and Morady are founders of Ablation Frontiers, report being major stockholders in Ablation Frontiers, and report having served as consultants to Ablation Frontiers and Biosense Webster. Dr. Pappone reports having received grant support from Biosense Webster, St. Jude Medical, Guidant, and Medtronic and having served as a consultant to Biosense Webster. Dr. Chugh reports having received lecture fees from Biosense Webster. No other potential conflict of interest relevant to this article was reported.
Drs. Oral and Pappone and Drs. Santinelli and Morady contributed equally to the article as first authors and senior authors, respectively.
Source Information
From the Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (H.O., A.C., E.G., F.B., F.P., E.R.B., M.H.L., F.M.); and the Electrophysiology and Cardiac Pacing Department, San Raffaele University Hospital, Milan (C.P., G.V., G.A., E.A., S.S., V.S.).
Address reprint requests to Dr. Oral at the Division of Cardiovascular Medicine, TCB1 140 D, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0311, or at oralh@umich.edu.
- References
References
1
Kottkamp H ,Tanner H ,Kobza R , et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J Am Coll Cardiol 2004;44:869-877
CrossRef | Web of Science | Medline2
Oral H ,Scharf C ,Chugh A , et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108:2355-2360
CrossRef | Web of Science | Medline3
Pappone C ,Manguso F ,Vicedomini G , et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation 2004;110:3036-3042
CrossRef | Web of Science | Medline4
Pappone C ,Oreto G ,Rosanio S , et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001;104:2539-2544
CrossRef | Web of Science | Medline5
Pappone C ,Rosanio S ,Augello G , et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42:185-197
CrossRef | Web of Science | Medline6
Jalife J . Rotors and spiral waves in atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:776-780
CrossRef | Web of Science | Medline7
Nademanee K ,McKenzie J ,Kosar E , et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43:2044-2053
CrossRef | Web of Science | Medline8
Pappone C ,Santinelli V ,Manguso F , et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109:327-334
CrossRef | Web of Science | Medline9
Stabile G ,Turco P ,La Rocca V ,Nocerino P ,Stabile E ,De Simone A . Is pulmonary vein isolation necessary for curing atrial fibrillation? Circulation 2003;108:657-660
CrossRef | Web of Science | Medline10
Moe GK . A conceptual model of atrial fibrillation. J Electrocardiol 1968;1:145-146
CrossRef | Medline11
Lin WS ,Tai CT ,Hsieh MH , et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 2003;107:3176-3183
CrossRef | Web of Science | Medline12
Lemola K ,Sneider M ,Desjardins B , et al. Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins. Heart Rhythm 2004;1:576-581
CrossRef | Web of Science | Medline13
Pappone C ,Oral H ,Santinelli V , et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004;109:2724-2726
CrossRef | Web of Science | Medline14
Scanavacca MI ,D'Avila A ,Parga J ,Sosa E . Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:960-962
CrossRef | Web of Science | Medline15
Han J ,Good E ,Morady F ,Oral H . Images in cardiovascular medicine: esophageal migration during left atrial catheter ablation for atrial fibrillation. Circulation 2004;110:e528-e528
CrossRef | Web of Science | Medline16
Wyse DG ,Waldo AL ,DiMarco JP , et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833
Full Text | Web of Science | Medline
- Citing Articles (307)
Citing Articles
1
KEITH GOLDEN, JOHN PAUL MOUNSEY, EUGENE CHUNG, PAHRESAH ROOMIANI, MICHAEL ANDEW MORSE, ANKIT PATEL, ANIL GEHI. (2012) Atrial Fibrillation Ablation Using a Closed Irrigation Radiofrequency Ablation Catheter. Pacing and Clinical Electrophysiologyno-no
CrossRef2
Rudolph F. Evonich, David M. Nori, David E. Haines. (2012) Efficacy of pulmonary vein isolation with a novel hot balloon ablation catheter. Journal of Interventional Cardiac Electrophysiology
CrossRef3
Jin-Bae Kim, Seonghoon Choi, Boyoung Joung, Moon-Hyoung Lee, Sung-Soon Kim. (2012) The Effects of a Bidirectional Cavo-Tricuspid Isthmus Block in Persistent Atrial Fibrillation. Yonsei Medical Journal 53:1, 76
CrossRef4
Akinori Sairaku, Yukiko Nakano, Noboru Oda, Yuko Makita, Kenta Kajihara, Takehito Tokuyama, Chikaaki Motoda, Mai Fujiwara, Yasuki Kihara. (2012) Prediction of sinus node dysfunction in patients with long-standing persistent atrial fibrillation using the atrial fibrillatory cycle length. Journal of Electrocardiology
CrossRef5
Wazni, Oussama, Wilkoff, Bruce, Saliba, Walid, . (2011) Catheter Ablation for Atrial Fibrillation. New England Journal of Medicine 365:24, 2296-2304
Full Text6
Pasquale Santangeli, Luigi Di Biase, David J. Burkhardt, Rodney Horton, Javier Sanchez, Rong Bai, Agnes Pump, Marco Perez, Paul J. Wang, Andrea Natale, Amin Al-Ahmad. (2011) Catheter ablation of atrial fibrillation. Journal of Cardiovascular Medicine1
CrossRef7
J. Zhuang, Y. Wang, K. Tang, X. Li, W. Peng, C. Liang, Y. Xu. (2011) Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace
CrossRef8
J. P. Joseph, K. Rajappan. (2011) Radiofrequency ablation of cardiac arrhythmias: past, present and future. QJM
CrossRef9
Kentaro Yoshida, Amir B. Rabbani, Hakan Oral, David Bach, Fred Morady, Aman Chugh. (2011) Left atrial volume and dominant frequency of atrial fibrillation in patients undergoing catheter ablation of persistent atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 32:2, 155-161
CrossRef10
Dimpi Patel, Luciana V Armaganijan, Carlos A Morillo. (2011) Atrial fibrillation catheter ablation in females: same hardware, different findings. Expert Review of Cardiovascular Therapy 9:11, 1391-1395
CrossRef11
THOMAS JARED BUNCH, JOHN D. DAY. (2011) Achieving Favorable Very Long-Term Outcomes After Catheter Ablation for Atrial Fibrillation: An Exciting Adventure or Delusional Quest?. Journal of Cardiovascular Electrophysiology 22:11, 1215-1216
CrossRef12
CLAUDE S. ELAYI, LUIGI DI BIASE, RONG BAI, J. DAVID BURKHARDT, PRASANT MOHANTY, JAVIER SANCHEZ, PASQUALE SANTANGELI, RICHARD HONGO, G. JOSEPH GALLINGHOUSE, RODNEY HORTON, SHANE BAILEY, JASON ZAGRODZKY, SALWA BEHEIRY, ANDREA NATALE. (2011) Identifying the Relationship Between the Non-PV Triggers and the Critical CFAE Sites Post-PVAI to Curtail the Extent of Atrial Ablation in Longstanding Persistent AF. Journal of Cardiovascular Electrophysiology 22:11, 1199-1205
CrossRef13
ROY BEINART, SUHNY ABBARA, ANDREW BLUM, MAROS FERENCIK, KEVIN HEIST, JEREMY RUSKIN, MOUSSA MANSOUR. (2011) Left Atrial Wall Thickness Variability Measured by CT Scans
in Patients Undergoing Pulmonary Vein Isolation. Journal of Cardiovascular Electrophysiology 22:11, 1232-1236
CrossRef14
Jeff S. Healey, Girish M. Nair. (2011) Does catheter ablation for atrial fibrillation increase or reduce neurological insult?. Current Opinion in Cardiology1
CrossRef15
Naiara Calvo, Mercé Nadal, Antonio Berruezo, David Andreu, Elena Arbelo, Jose Maria Tolosana, Eduard Guasch, Maria Matiello, Maria Matas, Xavier Alsina, Marta Sitges, Josep Brugada, Lluís Mont. (2011) Evolución de la mejora en los resultados y las complicaciones de la ablación por catéter de la fibrilación auricular: aprendizaje, técnicas y metodología. Revista Española de Cardiología
CrossRef16
Naiara Calvo, Mercé Nadal, Antonio Berruezo, David Andreu, Elena Arbelo, Jose Maria Tolosana, Eduard Guasch, Maria Matiello, Maria Matas, Xavier Alsina, Marta Sitges, Josep Brugada, Lluís Mont. (2011) Improved Outcomes and Complications of Atrial Fibrillation Catheter Ablation Over Time: Learning Curve, Techniques, and Methodology. Revista Española de Cardiología (English Edition)
CrossRef17
Edward P. Gerstenfeld. (2011) New Technologies for Catheter Ablation of Atrial Fibrillation. Current Treatment Options in Cardiovascular Medicine 13:5, 393-401
CrossRef18
ANDREW W. TEH, PETER M. KISTLER, GEOFFREY LEE, CAROLINE MEDI, PATRICK M. HECK, STEVEN SPENCE, JOSEPH B. MORTON, PRASHANTHAN SANDERS, JONATHAN M. KALMAN. (2011) Electroanatomic Properties of the Pulmonary Veins: Slowed Conduction, Low Voltage and Altered Refractoriness in AF Patients. Journal of Cardiovascular Electrophysiology 22:10, 1083-1091
CrossRef19
V. Wadehra, A. E. Buxton, A. P. Antoniadis, J. W. McCready, C. J. Redpath, O. R. Segal, E. Rowland, M. D. Lowe, P. D. Lambiase, A. W. C. Chow. (2011) The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace 13:10, 1401-1405
CrossRef20
Min-Ho Song, Takuya Maeda, Yasuyuki Toyoda, Masakuni Ishiyama. (2011) Midterm Results of Surgical Box Line Ablation for Atrial Fibrillation by Bipolar Radiofrequency. Journal of Cardiac Surgeryno-no
CrossRef21
Roberto Rordorf, Simone Savastano, Edoardo Gandolfi, Alessandro Vicentini, Barbara Petracci, Maurizio Landolina. (2011) Pharmacological therapy following catheter ablation of atrial fibrillation. Journal of Cardiovascular Medicine1
CrossRef22
Jinqi Fan, Hua Cao, Li Su, Zhiyu Ling, Zengzhang Liu, Xianbin Lan, Yanping Xu, Weijie Chen, Yuehui Yin. (2011) NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation. Journal of Interventional Cardiac Electrophysiology
CrossRef23
A. John Camm, Carina Blomström-Lundqvist, Paul Dorian, Stefan H. Hohnloser, Carlos A. Morillo, Pasquale Santangeli, Isabelle C. van Gelder, Erik Wissner, Paulus Kirchhof. 2011. Clinical Trials on Atrial Fibrillation/Future Perspectives. , 137-160.
CrossRef24
Eric N. Prystowsky, Josep Brugada, Samuel Lévy, Matthew Reynolds, Vincenzo Santinelli, Panos E. Vardas, Francesca Zuffada, Carlo Pappone. 2011. Indications to Atrial Fibrillation Ablation and Cost-Effectiveness. , 127-136.
CrossRef25
Hugh Calkins, Emanuele Bertaglia, Antonio Berruezo, Aldo Bonso, Jonathan M. Kalman, Moussa Mansour, Atul Verma. 2011. Short- and Long-Term Efficacy of Catheter Ablation Procedures for Atrial fibrillation. , 118-126.
CrossRef26
JACOB S. KORUTH, VIVEK Y. REDDY, MARC A. MILLER, KALPESH K. PATEL, JAMES O. COFFEY, AVI FISCHER, J. ANTHONY GOMES, SRINIVAS DUKKIPATI, ANDRE D’AVILA, ALEXANDER MITTNACHT. (2011) Mechanical Esophageal Displacement During Catheter Ablation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiologyno-no
CrossRef27
Jonathan P. Piccini, James P. Daubert. (2011) Cryoablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology
CrossRef28
Nicolas Lellouche, Frederic A. Sebag, Nathalie Elbaz, Majed Hassine, Najia Chaachoui, Emmanuel Teiger, Jean-Luc Dubois-Randé, Pascal Lim. (2011) Acute pericardial effusion following atrial fibrillation ablation: Characteristics and relationship with arrhythmia recurrences. Archives of Cardiovascular Diseases 104:8-9, 450-457
CrossRef29
Thomas Deneke, Andreas Mügge, Osman Balta, Marc Horlitz, Peter H Grewe, Dong-In Shin. (2011) Treatment of persistent atrial fibrillation using phased radiofrequency ablation technology. Expert Review of Cardiovascular Therapy 9:8, 1041-1049
CrossRef30
Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, 1340-1356
CrossRef31
Georg Nölker, Klaus Jürgen Gutleben, Guido Ritscher, Harald Rittger, Stefan Asbach, Johannes Heintze, Bogdan Muntean, Jürgen Vogt, Johannes Brachmann, Dieter Horstkotte, Anil Martin Sinha. (2011) Left atrial lesion formation and volume overload by open irrigation ablation technology during pulmonary vein antrum isolation: acute effects on cardiac hemodynamics. Journal of Interventional Cardiac Electrophysiology 31:2, 125-130
CrossRef32
T. JARED BUNCH, BRIAN G. CRANDALL, J. PETER WEISS, HEIDI T. MAY, TAMI L. BAIR, JEFFREY S. OSBORN, JEFFREY L. ANDERSON, JOSEPH B. MUHLESTEIN, BENJAMIN D. HORNE, DONALD L. LAPPE, JOHN D. DAY. (2011) Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 22:8, 839-845
CrossRef33
A. Sairaku, Y. Nakano, N. Oda, Y. Makita, K. Kajihara, T. Tokuyama, C. Motoda, M. Fujiwara, Y. Kihara. (2011) How many electrical cardioversions should be applied for repetitive recurrences of atrial arrhythmias following ablation of persistent atrial fibrillation?. Europace
CrossRef34
A. A. W. Mulder, M. C. E. F. Wijffels, E. F. D. Wever, L. V. A. Boersma. (2011) Pulmonary vein isolation and left atrial complex-fractionated atrial electrograms ablation for persistent atrial fibrillation with phased radio frequency energy and multi-electrode catheters: efficacy and safety during 12 months follow-up. Europace
CrossRef35
Christopher McGann, Eugene Kholmovski, Joshua Blauer, Sathya Vijayakumar, Thomas Haslam, Joshua Cates, Edward DiBella, Nathan Burgon, Brent Wilson, Alton Alexander, Marcel Prastawa, Marcos Daccarett, Gaston Vergara, Nazem Akoum, Dennis Parker, Rob MacLeod, Nassir Marrouche. (2011) Dark Regions of No-Reflow on Late Gadolinium Enhancement Magnetic Resonance Imaging Result in Scar Formation After Atrial Fibrillation Ablation. Journal of the American College of Cardiology 58:2, 177-185
CrossRef36
Andrew J. Brenyo, Mehmet K. Aktas. (2011) Non-Pharmacologic Management of Atrial Fibrillation. The American Journal of Cardiology 108:2, 317-325
CrossRef37
RATIKA PARKASH, ANTHONY S.L. TANG, JOHN L. SAPP, GEORGE WELLS. (2011) Approach to the Catheter Ablation Technique of Paroxysmal and Persistent Atrial Fibrillation: A Meta-Analysis of the Randomized Controlled Trials. Journal of Cardiovascular Electrophysiology 22:7, 729-738
CrossRef38
James R. Edgerton, Cecile Mahoney, Michael J. Mack, Karen Roper, Morley A. Herbert. (2011) Long-term monitoring after surgical ablation for atrial fibrillation: How much is enough?. The Journal of Thoracic and Cardiovascular Surgery 142:1, 162-165
CrossRef39
AURELIE GUIOT, KRIT JONGNARANGSIN, AMAN CHUGH, ARISARA SUWANAGOOL, RAKESH LATCHAMSETTY, JAMES D. MYLES, QINGMEI JIANG, THOMAS CRAWFORD, ERIC GOOD, FRANK PELOSI JR, FRANK BOGUN, FRED MORADY, HAKAN ORAL. (2011) Anticoagulant Therapy and Risk of Cerebrovascular Events After Catheter Ablation of Atrial Fibrillation in the Elderly. Journal of Cardiovascular Electrophysiologyno-no
CrossRef40
P. Defaye, A. Kane, A. Chaib, P. Jacon. (2011) Efficacy and safety of pulmonary veins isolation by cryoablation for the treatment of paroxysmal and persistent atrial fibrillation. Europace 13:6, 789-795
CrossRef41
Wai Kah Choo, David Farwell, Stuart Harris. (2011) Experience of atrial fibrillation ablation in a new cardiac centre using three-dimensional mapping and multielectrode duty-cycled radiofrequency ablation. Archives of Cardiovascular Diseases 104:6-7, 396-402
CrossRef42
N. A. Mark Estes, Munther Homoud, Jonathan Weinstock, Caroline Foote, Ania Garlitski, Mark Link, Afshin Ehsan. (2011) Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. Journal of Interventional Cardiac Electrophysiology 31:1, 91-99
CrossRef43
Stefan G. Spitzer, Laszlo Karolyi. (2011) Katheterablation von Vorhofflimmern. Clinical Research in Cardiology Supplements 6:S1, 66-72
CrossRef44
Laurent M Haegeli, Firat Duru. (2011) Atrial fibrillation in the aging heart: pharmacological therapy and catheter ablation in the elderly. Future Cardiology 7:3, 415-423
CrossRef45
J. Kautzner, V. Bulkova, G. Hindricks, N. Maniadakis, P. Della Bella, P. Jais, K.-H. Kuck. (2011) Atrial fibrillation ablation: a cost or an investment?. Europace 13:Supplement 2, ii39-ii43
CrossRef46
A. Hakalahti, P. Uusimaa, K. Ylitalo, M. J. P. Raatikainen. (2011) Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace 13:5, 640-645
CrossRef47
Koki Nakamura, Nobusada Funabashi, Masae Uehara, Marehiko Ueda, Taichi Murayama, Hiroyuki Takaoka, Issei Komuro. (2011) Left atrial wall thickness in paroxysmal atrial fibrillation by multislice-CT is initial marker of structural remodeling and predictor of transition from paroxysmal to chronic form. International Journal of Cardiology 148:2, 139-147
CrossRef48
Tiago Luiz Luz Leiria, Tamara Glavinovic, J. Andrew Armour, René Cardinal, Gustavo Glotz de Lima, Teresa Kus. (2011) Longterm effects of cardiac mediastinal nerve cryoablation on neural inducibility of atrial fibrillation in canines. Autonomic Neuroscience 161:1-2, 68-74
CrossRef49
Milos Kesek, Folke Rönn, Titti Tollefsen, Niklas Höglund, Ulf Näslund, Steen M. Jensen. (2011) Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22. Upsala Journal of Medical Sciences 116:1, 52-59
CrossRef50
M. H. Kong, J. P. Piccini, T. D. Bahnson. (2011) Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials. Europace 13:2, 193-204
CrossRef51
Hui-Nam Pak, Yong Seog Oh, Hong Euy Lim, Young-Hoon Kim, Chun Hwang. (2011) Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation. Heart Rhythm 8:2, 199-206
CrossRef52
Y. Komatsu, K. Uno, K. Otomo, Y. Nagata, H. Taniguchi, K. Ogura, Y. Egami, K. Takayama, K. Kakita, Y. Iesaka. (2011) Atrial defibrillation threshold as a novel predictor of clinical outcome of catheter ablation for persistent atrial fibrillation. Europace 13:2, 213-220
CrossRef53
Laurent M. Haegeli, Firat Duru. (2011) Management of Patients with Atrial Fibrillation: Specific Considerations for the Old Age. Cardiology Research and Practice 2011, 1-8
CrossRef54
Carlo Pappone, Gabriele Vicedomini, Enrico Frigoli, Luigi Giannelli, Cristiano Ciaccio, Mario Baldi, Francesca Zuffada, Massimo Saviano, Alessia Pappone, Simonetta Crisà, Andrea Petretta, Vincenzo Santinelli. (2011) Irrigated-tip magnetic catheter ablation of AF: A long-term prospective study in 130 patients. Heart Rhythm 8:1, 8-15
CrossRef55
Juan F. Viles-Gonzalez, Valentin Fuster, Jonathan Halperin, Hugh Calkins, Vivek Y. Reddy. (2011) Rhythm Control for Management of Patients With Atrial Fibrillation: Balancing the Use of Antiarrhythmic Drugs and Catheter Ablation. Clinical Cardiology 34:1, 23-29
CrossRef56
Hui-Nam Pak. (2011) Large Circular Ring Catheter Ablation Versus Anatomically Guided Ablation of Atrial Fibrillation: Back to the Future for Successful Catheter Ablation of Atrial Fibrillation?. Korean Circulation Journal 41:8, 431
CrossRef57
ANTONIO NAVARRETE, FRANK CONTE, MICHAEL MORAN, ISHTI ALI, NATHAN MILIKAN. (2011) Ablation of Atrial Fibrillation at the Time of Cavotricuspid Isthmus Ablation in Patients With Atrial Flutter Without Documented Atrial Fibrillation Derives a Better Long-Term Benefit. Journal of Cardiovascular Electrophysiology 22:1, 34-38
CrossRef58
L. Samuel Wann, Anne B. Curtis, Craig T. January, Kenneth A. Ellenbogen, James E. Lowe, N.A. Mark Estes, Richard L. Page, Michael D. Ezekowitz, David J. Slotwiner, Warren M. Jackman, William G. Stevenson, Cynthia M. Tracy, Valentin Fuster, Lars E. Rydén, David S. Cannom, Jean-Yves Le Heuzey, Harry J. Crijns, James E. Lowe, Anne B. Curtis, S. Bertil Olsson, Kenneth A. Ellenbogen, Eric N. Prystowsky, Jonathan L. Halperin, Juan Luis Tamargo, G. Neal Kay, L. Samuel Wann. (2011) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline). Journal of the American College of Cardiology 57:2, 223-242
CrossRef59
L. Samuel Wann, Anne B. Curtis, Craig T. January, Kenneth A. Ellenbogen, James E. Lowe, N.A. Mark Estes, Richard L. Page, Michael D. Ezekowitz, David J. Slotwiner, Warren M. Jackman, William G. Stevenson, Cynthia M. Tracy. (2011) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline). Heart Rhythm 8:1, 157-176
CrossRef60
F. Dentali, M. Gianni, A. Squizzato, W. Ageno, L. Castiglioni, L. Maroni, E. M. Hylek, A. M. Grandi, E. Cazzani, A. Venco, L. Guasti. (2011) Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. Thrombosis and Haemostasis 106:2, 363-370
CrossRef61
A. Arya, R. Zaker-Shahrak, P. Sommer, A. Bollmann, U. Wetzel, T. Gaspar, S. Richter, D. Husser, C. Piorkowski, G. Hindricks. (2011) Catheter ablation of atrial fibrillation using remote magnetic catheter navigation: a case-control study. Europace 13:1, 45-50
CrossRef62
Klaus Kettering, Hans-Joerg Weig, Mathias Busch, Klaus Martin Schneider, Christian Eick, Slawomir Weretka, Roman Laszlo, Meinrad Gawaz, Juergen Schreieck. (2011) Catheter ablation of persistent atrial fibrillation: anatomically based circumferential pulmonary vein ablation in combination with a potential-guided segmental approach to achieve complete pulmonary vein isolation. Journal of Interventional Cardiac Electrophysiology 30:1, 63-72
CrossRef63
Raymond W. Sy, Lorne J. Gula, Peter Leong-Sit, George J. Klein, Raymond Yee, Andrew D. Krahn, Cathy Bentley, Shakeeb Razak, Allan C. Skanes. (2011) Complete antral encirclement is not required for pulmonary vein isolation. Heart Rhythm 8:1, 16-22
CrossRef64
JONG-IL CHOI, HUI-NAM PAK, JAE SEOK PARK, JAE JIN KWAK, YASUTSUGU NAGAMOTO, HONG EUY LIM, SANG WEON PARK, CHUN HWANG, YOUNG-HOON KIM. (2010) Clinical Significance of Early Recurrences of Atrial Tachycardia After Atrial Fibrillation Ablation. Journal of Cardiovascular Electrophysiology 21:12, 1331-1337
CrossRef65
A. Leenhardt, G. Moubarak, A. Messali, F. Extramiana. (2010) La fibrillation atriale est-elle un marqueur indépendant de risque cardio-vasculaire ?. Annales de Cardiologie et d'Angéiologie 59, S14-S18
CrossRef66
Kunihiro Nishida, Jean-François Sarrazin, Akira Fujiki, Hakan Oral, Hiroshi Inoue, Fred Morady, Stanley Nattel. (2010) Roles of the Left Atrial Roof and Pulmonary Veins in the Anatomic Substrate for Persistent Atrial Fibrillation and Ablation in a Canine Model. Journal of the American College of Cardiology 56:21, 1728-1736
CrossRef67
J. Paul Mounsey. (2010) Left Atrial Roof Ablation Is More Important Than Pulmonary Vein Isolation in Terminating Persistent Atrial Fibrillation in a Canine Model. Journal of the American College of Cardiology 56:21, 1737-1739
CrossRef68
Omer Berenfeld. (2010) Toward discerning the mechanisms of atrial fibrillation from surface electrocardiogram and spectral analysis. Journal of Electrocardiology 43:6, 509-514
CrossRef69
Suman S. Kuppahally, Nazem Akoum, Troy J. Badger, Nathan S. Burgon, Thomas Haslam, Eugene Kholmovski, Rob Macleod, Christopher McGann, Nassir F. Marrouche. (2010) Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. American Heart Journal 160:5, 877-884
CrossRef70
Mark D. O'Neill, Matthew Wright, Pierre Jaïs, Sebastien Knecht, Isabelle Nault, Seiichiro Matsuo, Shinsuke Miyazaki, Andrej Pernat, Amir Jadidi, Frédéric Sacher, D. Wyn Davies, Jacques Clémenty, Michel Haïssaguerre, Mélèze Hocini. 2010. Treatment of Atrial Arrhythmias in Heart Failure Patients. , 217-234.
CrossRef71
ANITA WOKHLU, DAVID O. HODGE, KRISTI H. MONAHAN, SAMUEL J. ASIRVATHAM, PAUL A. FRIEDMAN, THOMAS M. MUNGER, YONG-MEI CHA, WIN-KUANG SHEN, PETER A. BRADY, CHRISTINE M. BLUHM, JANIS M. HAROLDSON, STEPHEN C. HAMMILL, DOUGLAS L. PACKER. (2010) Long-Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence. Journal of Cardiovascular Electrophysiology 21:10, 1071-1078
CrossRef72
Sana M. Al-Khatib, Hugh Calkins, Benjamin C. Eloff, Peter Kowey, Stephen C. Hammill, Kenneth A. Ellenbogen, Danica Marinac-Dabic, Albert L. Waldo, Ralph G. Brindis, David J. Wilbur, Warren M. Jackman, Marcia S. Yaross, Andrea M. Russo, Eric Prystowsky, Paul D. Varosy, Thomas Gross, Ellen Pinnow, Mintu P. Turakhia, Mitchell W. Krucoff. (2010) Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: A Cardiac Safety Research Consortium “Incubator” Think Tank. American Heart Journal 160:4, 619-626.e1
CrossRef73
Mark Alber Meshil, Deepak Bhakta. (2010) REVIEW: Nonpharmacological Therapies for Atrial Fibrillation. Cardiovascular Therapeutics 28:5, 264-277
CrossRef74
ROLAND RICHARD TILZ, K.R. JULIAN CHUN, BORIS SCHMIDT, ALEXANDER FUERNKRANZ, ERIK WISSNER, ILKA KOESTER, DIETMAR BAENSCH, SIGRID BOCZOR, BUELENT KOEKTUERK, ANDREAS METZNER, THOMAS ZERM, SABINE ERNST, MATTHIAS ANTZ, KARL-HEINZ KUCK, FEIFAN OUYANG. (2010) Catheter Ablation of Long-Standing Persistent Atrial Fibrillation: A Lesson from Circumferential Pulmonary Vein Isolation. Journal of Cardiovascular Electrophysiology 21:10, 1085-1093
CrossRef75
Arnold Pinter, Paul Dorian. (2010) REVIEW: New Approaches to Atrial Fibrillation Management: Treat the Patient, not the ECG. Cardiovascular Therapeutics 28:5, 302-310
CrossRef76
Masatoshi Yamazaki, Sherry Morgenstern, Matthew Klos, Katherine Campbell, Daniel Buerkel, Jérôme Kalifa. (2010) Left atrial coronary perfusion territories in isolated sheep hearts: Implications for atrial fibrillation maintenance. Heart Rhythm 7:10, 1501-1508
CrossRef77
Laurent M. Haegeli, Firat Duru, Evan E. Lockwood, Thomas F. Lüscher, Laurence D. Sterns, Paul G. Novak, Richard A. Leather. (2010) Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome. Journal of Interventional Cardiac Electrophysiology 28:3, 193-197
CrossRef78
Claude S. Elayi, Luigi Di Biase, Conor Barrett, Chi Keong Ching, Moataz al Aly, Maria Lucciola, Rong Bai, Rodney Horton, Tamer S. Fahmy, Atul Verma, Yaariv Khaykin, Jignesh Shah, Gustavo Morales, Richard Hongo, Steven Hao, Salwa Beheiry, Mauricio Arruda, Robert A. Schweikert, Jennifer Cummings, J. David Burkhardt, Paul Wang, Amin Al-Ahmad, Bruno Cauchemez, Fiorenzo Gaita, Andrea Natale. (2010) Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm 7:9, 1216-1223
CrossRef79
Elad Anter, David J. Callans. (2010) Can Ablation Prevent the Excess Mortality of Atrial Fibrillation?. Current Cardiology Reports 12:5, 389-392
CrossRef80
GEOFFREY LEE, PAUL B. SPARKS, JOSEPH B. MORTON, PETER M. KISTLER, JITENDRA K. VOHRA, CAROLINE MEDI, RAPHAEL ROSSO, ANDREW TEH, KAREN HALLORAN, JONATHAN M. KALMAN. (2010) Low Risk of Major Complications Associated With Pulmonary Vein Antral Isolation for Atrial Fibrillation: Results of 500 Consecutive Ablation Procedures in Patients With Low Prevalence of Structural Heart Disease From a Single Center. Journal of Cardiovascular Electrophysiologyno-no
CrossRef81
Sara R. Vazquez, Stacy A. Johnson, Matthew T. Rondina. (2010) Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thrombosis Research 126:2, e69-e77
CrossRef82
Sandeep Arora, Farouk Mookadam, Komandoor Srivathsan. (2010) Interventional management of atrial fibrillation. Expert Review of Cardiovascular Therapy 8:7, 949-958
CrossRef83
Benjamin R Knowles, Dennis Caulfield, Michael Cooklin, C Aldo Rinaldi, Jaswinder Gill, Julian Bostock, Reza Razavi, Tobias Schaeffter, Kawal S Rhode. (2010) 3-D Visualization of Acute RF Ablation Lesions Using MRI for the Simultaneous Determination of the Patterns of Necrosis and Edema. IEEE Transactions on Biomedical Engineering 57:6, 1467-1475
CrossRef84
AMAN CHUGH, HAKAN ORAL. (2010) Delayed Activation of the Left Atrial Appendage Following Catheter Ablation of Persistent Atrial Fibrillation: A Cause for Concern?. Pacing and Clinical Electrophysiology 33:6, 649-651
CrossRef85
JAE-JIN KWAK, HUI-NAM PAK, JIN-KUN JANG, SOOK KYOUNG KIM, JAE HYUNG PARK, JONG-IL CHOI, CHUN HWANG, YOUNG-HOON KIM. (2010) Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 21:6, 620-625
CrossRef86
Anthony G. Brooks, Martin K. Stiles, Julien Laborderie, Dennis H. Lau, Pawel Kuklik, Nicholas J. Shipp, Li-Fern Hsu, Prashanthan Sanders. (2010) Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review. Heart Rhythm 7:6, 835-846
CrossRef87
DAVID J. WILBER. (2010) DeCFAEnating Atrial Fibrillation: Narrowing the Targets. Journal of Cardiovascular Electrophysiology 21:6, 617-619
CrossRef88
Carlo Bonanno, Mariemma Paccanaro, Luigi La Vecchia, Renato Ometto, Alessandro Fontanelli. (2010) Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. Journal of Cardiovascular Medicine 11:6, 408-418
CrossRef89
SACHIN S. PARIKH, CHRISTIAN JONS, SCOTT MCNITT, JAMES P. DAUBERT, KARL Q. SCHWARZ, BURR HALL. (2010) Predictive Capability of Left Atrial Size Measured by CT, TEE, and TTE for Recurrence of Atrial Fibrillation Following Radiofrequency Catheter Ablation. Pacing and Clinical Electrophysiology 33:5, 532-540
CrossRef90
L. Capulzini, G. Paparella, A. Sorgente, C. de Asmundis, G. B. Chierchia, A. Sarkozy, A. Muller-Burri, Y. Yazaki, M. Roos, P. Brugada. (2010) Feasibility, safety, and outcome of a challenging transseptal puncture facilitated by radiofrequency energy delivery: a prospective single-centre study. Europace 12:5, 662-667
CrossRef91
ANDREA M. RUSSO. (2010) Is Atrial Fibrillation Ablation a Futile Effort in Patients Who Have Markedly Enlarged Left Atria?. Pacing and Clinical Electrophysiology 33:5, 527-531
CrossRef92
Demosthenes Katritsis, Faisal M. Merchant, Theofanie Mela, Jagmeet P. Singh, E. Kevin Heist, Antonis A. Armoundas. (2010) Catheter Ablation of Atrial Fibrillation. Journal of the American College of Cardiology 55:21, 2293-2298
CrossRef93
David Tamborero, Lluís Mont, Antonio Berruezo, Eduard Guasch, Jose Rios, Mercedes Nadal, Maria Matiello, David Andreu, Marta Sitges, Josep Brugada. (2010) Circumferential pulmonary vein ablation: Does use of a circular mapping catheter improve results? A prospective randomized study. Heart Rhythm 7:5, 612-618
CrossRef94
I. Nault, S. Miyazaki, A. Forclaz, M. Wright, A. Jadidi, P. Jais, M. Hocini, M. Haissaguerre. (2010) Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. European Heart Journal 31:9, 1046-1054
CrossRef95
H. Kato, S. Kubota, Y. Yamada, T. Kumamoto, Y. Takasawa, N. Takahashi, M. Yamamoto. (2010) Circumferential pulmonary vein ablation of atrial fibrillation via superior vena cava approach in a patient with interruption of the inferior vena cava. Europace 12:5, 746-748
CrossRef96
Jason E. Taclas, Reza Nezafat, John V. Wylie, Mark E. Josephson, Jeff Hsing, Warren J. Manning, Dana C. Peters. (2010) Relationship between intended sites of RF ablation and post-procedural scar in AF patients, using late gadolinium enhancement cardiovascular magnetic resonance. Heart Rhythm 7:4, 489-496
CrossRef97
Omer Berenfeld. (2010) Spatiotemporal and spectral characteristics of atrial fibrillation waves across atrial walls and remodeling. Heart Rhythm 7:4, 518-519
CrossRef98
Tushar V Salukhe, Stephan Willems, Daniel Steven, Boris A Hoffmann, Imke Drewitz, Thomas Rostock. (2010) Second-generation atrial tachycardias: adverse repercussions of ablation or a step in the right direction?. Interventional Cardiology 2:2, 137-145
CrossRef99
D. Shah. (2010) Pulmonary vein isolation with the pulmonary vein ablation catheter (PVAC): is there a price to pay for a 'simpler', shorter procedure?. Europace 12:4, 455-457
CrossRef100
Ulrich Halm, Thomas Gaspar, Markus Zachäus, Stephan Sack, Arash Arya, Christopher Piorkowski, Ingrid Knigge, Gerhard Hindricks, Daniela Husser. (2010) Thermal Esophageal Lesions After Radiofrequency Catheter Ablation of Left Atrial Arrhythmias. The American Journal of Gastroenterology 105:3, 551-556
CrossRef101
Mélèze Hocini, Isabelle Nault, Matthew Wright, George Veenhuyzen, Sanjiv M. Narayan, Pierre Jaïs, Kang-Teng Lim, Sébastien Knecht, Seiichiro Matsuo, Andrei Forclaz, Shinsuke Miyazaki, Amir Jadidi, Mark D. O'Neill, Frédéric Sacher, Jacques Clémenty, Michel Haïssaguerre. (2010) Disparate Evolution of Right and Left Atrial Rate During Ablation of Long-Lasting Persistent Atrial Fibrillation. Journal of the American College of Cardiology 55:10, 1007-1016
CrossRef102
P. Sommer, G. Hindricks. (2010) Iatrogenic atrial septal defect after catheter ablation of atrial fibrillation: do we have to worry?. Europace 12:3, 301-302
CrossRef103
E. Pokushalov, A. Romanov, S. Artyomenko, A. Turov, P. Shugayev, N. Shirokova, D. G. Katritsis. (2010) Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace 12:3, 342-346
CrossRef104
F. Arribas, J. M. Ormaetxe, R. Peinado, N. Perulero, P. Ramirez, X. Badia. (2010) Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace 12:3, 364-370
CrossRef105
A. Chugh, H. Oral. (2010) Circumferential pulmonary vein ablation for atrial fibrillation: back to the future?. Europace 12:2, 149-150
CrossRef106
A. Arya, G. Hindricks, P. Sommer, Y. Huo, A. Bollmann, T. Gaspar, K. Bode, D. Husser, H. Kottkamp, C. Piorkowski. (2010) Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 12:2, 173-180
CrossRef107
Jennifer L. Hall, Ana Barac, Emelia J. Benjamin. (2010) Genetic Mutations as Risk Predictors of Atrial Fibrillation Recurrence After Catheter Ablation?. Journal of the American College of Cardiology 55:8, 754-757
CrossRef108
E. Bertaglia, C. Tondo, A. De Simone, F. Zoppo, M. Mantica, P. Turco, A. Iuliano, G. Forleo, V. La Rocca, G. Stabile. (2010) Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace 12:2, 181-187
CrossRef109
Atsushi Takahashi. (2010) Non-pharmacological therapy for atrial fibrillation: catheter ablation based on extensive pulmonary vein isolation.. Folia Pharmacologica Japonica 135:2, 66-69
CrossRef110
Jean-Benoît le Polain de Waroux, Mario Talajic, Paul Khairy, Peter G Guerra, Denis Roy, Bernard Thibault, Marc Dubuc, Laurent Macle. (2010) Pulmonary vein isolation for the treatment of atrial fibrillation: past, present and future. Future Cardiology 6:1, 51-66
CrossRef111
Jae Hyung Park, Sang Weon Park, Jong Youn Kim, Sook Kyoung Kim, Boyoung Jeoung, Moon-Hyung Lee, Chun Hwang, Young-Hoon Kim, Sung Soon Kim, Hui-Nam Pak. (2010) Characteristics of Complex Fractionated Atrial Electrogram in the Electroanatomically Remodeled Left Atrium of Patients With Atrial Fibrillation. Circulation Journal 74:8, 1557-1563
CrossRef112
Andrew D. Choi, Khashayar Hematpour, Marrick Kukin, Suneet Mittal, Jonathan S. Steinberg. (2010) Ablation vs Medical Therapy in the Setting of Symptomatic Atrial Fibrillation and Left Ventricular Dysfunction. Congestive Heart Failure 16:1, 10-14
CrossRef113
SHUN'ICHIRO MIYOSHI. (2010) Japanese Journal of Electrocardiology 30:1, 80-85
CrossRef114
Sana M. Al-Khatib, Hugh Calkins, Benjamin C. Eloff, Douglas L. Packer, Kenneth A. Ellenbogen, Stephen C. Hammill, Andrea Natale, Richard L. Page, Eric Prystowsky, Warren M. Jackman, William G. Stevenson, Albert L. Waldo, David Wilber, Peter Kowey, Marcia S. Yaross, Daniel B. Mark, James Reiffel, John K. Finkle, Danica Marinac-Dabic, Ellen Pinnow, Phillip Sager, Art Sedrakyan, Daniel Canos, Thomas Gross, Elise Berliner, Mitchell W. Krucoff. (2010) Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: A Cardiac Safety Research Consortium “Incubator” Think Tank. American Heart Journal 159:1, 17-24.e1
CrossRef115
Atsushi Takahashi. (2010) Catheter Ablation Is Established as a Treatment Option for Atrial Fibrillation. Circulation Journal 74:9, 1972-1977
CrossRef116
Gi-Byoung Nam, Eun-Sun Jin, HyungOh Choi, Hae-Geun Song, Sung-Hwan Kim, Ki-Hun Kim, Eui-Seock Hwang, Kyoung-Min Park, Jun Kim, Kyoung-Suk Rhee, Kee-Joon Choi, You-Ho Kim. (2010) Mechanism of Regular Atrial Tachyarrhythmias During Combined Pulomonary Vein Isolation and Complex Fractionated Electrogram Ablation in Patients With Atrial Fibrillation. Circulation Journal 74:3, 434-441
CrossRef117
JCS Joint Working Group. (2010) Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008). Circulation Journal 74:11, 2479-2500
CrossRef118
Eui-Seock Hwang, Hui-Nam Pak, Sang Weon Park, Jong Sung Park, Boyoung Joung, Donghoon Choi, Moon-Hyoung Lee, Young Hoon Kim. (2010) Risks and Benefits of an Open Irrigation Tip Catheter in Intensive Radiofrequency Catheter Ablation in Patients With Non-Paroxysmal Atrial Fibrillation. Circulation Journal 74:4, 644-649
CrossRef119
Laurent M. Haegeli, Thomas Wolber, Ercüment Ercin, Lukas Altwegg, Nazmi Krasniqi, Paul G. Novak, Laurence D. Sterns, Corinna B. Brunckhorst, Thomas F. Lüscher, Richard A. Leather, Firat Duru. (2010) Double Transseptal Puncture for Catheter Ablation of Atrial Fibrillation: Safety of the Technique and Its Use in the Outpatient Setting. Cardiology Research and Practice 2010, 1-5
CrossRef120
Seiichiro Matsuo, Matthew Wright, Sébastien Knecht, Isabelle Nault, Nicolas Lellouche, Kang-Teng Lim, Leonardo Arantes, Mark D. O'Neill, Mélèze Hocini, Pierre Jaïs, Michel Haïssaguerre. (2010) Peri-mitral atrial flutter in patients with atrial fibrillation ablation. Heart Rhythm 7:1, 2-8
CrossRef121
Duncan Chambers, Mark Rodgers, Nerys Woolacott. (2009) Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies. Journal of Clinical Epidemiology 62:12, 1253-1260.e4
CrossRef122
JAE HYUNG PARK, HUI-NAM PAK, EUN JEOUNG CHOI, JIN KUN JANG, SOOK KYOUNG KIM, DONG HOON CHOI, JONG IL CHOI, CHUN HWANG, YOUNG-HOON KIM. (2009) The Relationship Between Endocardial Voltage and Regional Volume in Electroanatomical Remodeled Left Atria in Patients with Atrial Fibrillation: Comparison of Three-Dimensional Computed Tomographic Images and Voltage Mapping. Journal of Cardiovascular Electrophysiology 20:12, 1349-1356
CrossRef123
Thomas Crawford, Hakan Oral. (2009) Current status and outcomes of catheter ablation for atrial fibrillation. Heart Rhythm 6:12, S12-S17
CrossRef124
Giuseppe Augello, Gabriele Vicedomini, Massimo Saviano, Simonetta Crisa, Patrizio Mazzone, Ombretta Ornago, Francesca Zuffada, Vincenzo Santinelli, Carlo Pappone. (2009) Pulmonary vein isolation after circumferential pulmonary vein ablation: Comparison between Lasso and three-dimensional electroanatomical assessment of complete electrical disconnection. Heart Rhythm 6:12, 1706-1713
CrossRef125
Richard Kobza, Andreas W. Schoenenberger, Paul Erne. (2009) Esophagus imaging for catheter ablation of atrial fibrillation: comparison of two methods with showing of esophageal movement. Journal of Interventional Cardiac Electrophysiology 26:3, 159-164
CrossRef126
SHELDON M. SINGH, E. KEVIN HEIST, JACOB S. KORUTH, CONOR D. BARRETT, JEREMY N. RUSKIN, MOUSSA C. MANSOUR. (2009) The Relationship Between Electrogram Cycle Length and Dominant Frequency in Patients with Persistent Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 20:12, 1336-1342
CrossRef127
Marisa Chard, Reza Tabrizchi. (2009) The role of pulmonary veins in atrial fibrillation: A complex yet simple story. Pharmacology & Therapeutics 124:2, 207-218
CrossRef128
Joachim R. Ehrlich, Stefan H. Hohnloser. (2009) Milestones in the management of atrial fibrillation. Heart Rhythm 6:11, S62-S67
CrossRef129
MAURICIO S. ARRUDA, LUCIANA ARMAGANIJAN, LUIGI DI BIASE, RASSOLL RASHIDI, ANDREA NATALE. (2009) Feasibility and Safety of Using an Esophageal Protective System to Eliminate Esophageal Thermal Injury: Implications on Atrial-Esophageal Fistula Following AF Ablation. Journal of Cardiovascular Electrophysiology 20:11, 1272-1278
CrossRef130
Jesús M. Paylos, Robert H. Hoyt, Clara Ferrero, Carmen Berrio, Arancha Rey, Isabel Delgado, Jesús J. Veiga, José L. Moreno. (2009) Aislamiento circunferencial completo de venas pulmonares por crioablación con catéter-balón en pacientes con fibrilación auricular paroxística. Revista Española de Cardiología 62:11, 1326-1331
CrossRef131
Thomas Deneke, Joris R de Groot, Marc Horlitz, Andreas Mügge, Peter H Grewe, Katrin Bünz, Annely Bastian, Ron Haberkorn-Butendeich, Dong-In Shin. (2009) Pulmonary vein isolation using a novel decapolar over-the-wire mapping and ablation catheter. Expert Review of Cardiovascular Therapy 7:11, 1341-1347
CrossRef132
Carlo Pappone, Vincenzo Santinelli. (2009) Ablación de la fibrilación auricular: ¿dónde estamos?. Revista Española de Cardiología 62:10, 1087-1091
CrossRef133
Liza A. Prudente, J. Randall Moorman, Douglas Lake, Yuping Xiao, Heather Greebaum, J. Michael Mangrum, John P. DiMarco, John D. Ferguson. (2009) Femoral vascular complications following catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 26:1, 59-64
CrossRef134
Christoph Scharf, Lucas Boersma, Wyn Davies, Prapa Kanagaratnam, Nicholas S. Peters, Vince Paul, Edward Rowland, Andrew Grace, Simon Fynn, Lam Dang, Hakan Oral, Fred Morady. (2009) Ablation of Persistent Atrial Fibrillation Using Multielectrode Catheters and Duty-Cycled Radiofrequency Energy. Journal of the American College of Cardiology 54:15, 1450-1456
CrossRef135
Sébastien Knecht, José Castro-Rodriguez, Matthew Wright, Emmanuel Tran-Ngoc, Marielle Morissens, Valentin Tatnga, Emmanuel Catez, Béatrice Peperstraete, Nassime Zaoui, Vanessa Op de Beek, Gabriela Flores Vivian, Nathalie Ngo Mandag, Pierre Decoodt, Thierry Verbeet. (2009) Catheter ablation for the treatment of persistent atrial fibrillation. Interventional Cardiology 1:1, 107-118
CrossRef136
BOAZ AVITALL. (2009) Toys Я Us: Do They Truly Work?. Journal of Cardiovascular Electrophysiology 20:10, 1149-1150
CrossRef137
SANDEEP JOSHI, ANDREW D. CHOI, GANESH S. KAMATH, FARBOD RAISZADEH, DANIEL MARRERO, APURVA BADHEKA, SUNEET MITTAL, JONATHAN S. STEINBERG. (2009) Prevalence, Predictors, and Prognosis of Atrial Fibrillation Early After Pulmonary Vein Isolation: Findings from 3 Months of Continuous Automatic ECG Loop Recordings. Journal of Cardiovascular Electrophysiology 20:10, 1089-1094
CrossRef138
Ziad F. Issa. (2009) Pulmonary vein antrum isolation: Enduring the test of time. Heart Rhythm 6:10, 1413-1414
CrossRef139
Jagmeet P. Singh, Fred Morady. (2009) Patient selection and classification for atrial fibrillation ablation: Thinking beyond duration. Heart Rhythm 6:10, 1522-1525
CrossRef140
YVES DE GREEF, DIRK STOCKMAN, MATTIAS DUYTSCHAEVER, YVES VANDEKERCKHOVE, RENE TAVERNIER. (2009) Initial Experience with the High-Density Mesh Ablation Catheter for Pulmonary Vein Isolation. Pacing and Clinical Electrophysiology 32:10, 1286-1293
CrossRef141
Patrick P. Kneeland, Margaret C. Fang. (2009) Trends in catheter ablation for atrial fibrillation in the United States. Journal of Hospital Medicine 4:7, E1-E5
CrossRef142
Ethan R. Ellis, Steven D. Culler, April W. Simon, Matthew R. Reynolds. (2009) Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm 6:9, 1267-1273
CrossRef143
Hamid Ghanbari, Martin Schmidt, Christian Machado, Nathan M Segerson, Marcos Daccarett. (2009) Ablation strategies for atrial fibrillation. Expert Review of Cardiovascular Therapy 7:9, 1091-1101
CrossRef144
Roopinder K. Sandhu, Luigi Biase, William R. Lewis, J. David Burkhardt, Alberto Diaz, Kara J. Quan, Andrea Natale. (2009) Rational patient selection for catheter ablation of atrial fibrillation. Current Cardiology Reports 11:5, 327-334
CrossRef145
Aman Chugh, Hakan Oral. (2009) Atrial fibrillation: Preventing serious complications during AF ablation. Nature Reviews Cardiology 6:9, 562-563
CrossRef146
NIKOLAOS DAGRES, GERHARD HINDRICKS, HANS KOTTKAMP, PHILIPP SOMMER, THOMAS GASPAR, KERSTIN BODE, ARASH ARYA, DANIELA HUSSER, LOUKIANOS S. RALLIDIS, DIMITRIOS TH. KREMASTINOS, CHRISTOPHER PIORKOWSKI. (2009) Complications of Atrial Fibrillation Ablation in a High-Volume Center in 1,000 Procedures: Still Cause for Concern?. Journal of Cardiovascular Electrophysiology 20:9, 1014-1019
CrossRef147
Paul S. Chan, Brahmajee K. Nallamothu, Hakan Oral. (2009) Amiodarone or Dronedarone for Atrial Fibrillation. Journal of the American College of Cardiology 54:12, 1096-1098
CrossRef148
Seiichiro Matsuo, Nicolas Lellouche, Matthew Wright, Michela Bevilacqua, Sébastien Knecht, Isabelle Nault, Kang-Teng Lim, Leonardo Arantes, Mark D. O'Neill, Pyotr G. Platonov, Jonas Carlson, Frederic Sacher, Mélèze Hocini, Pierre Jaïs, Michel Haïssaguerre. (2009) Clinical Predictors of Termination and Clinical Outcome of Catheter Ablation for Persistent Atrial Fibrillation. Journal of the American College of Cardiology 54:9, 788-795
CrossRef149
X. Lan, L. Su, Z. Ling, Z. Liu, J. Wu, X. Yang, B. Zrenner, Y. Yin. (2009) Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation. European Journal of Clinical Investigation 39:8, 657-663
CrossRef150
Matthew P. Smelley, Bradley P. Knight. (2009) Approaches to catheter ablation of persistent atrial fibrillation. Heart Rhythm 6:8, S33-S38
CrossRef151
S. K. Kim, H.-N. Pak, J. H. Park, J. I. Choi, M.-H. Nam, Y. Jo, Y.-H. Kim. (2009) Non-ischaemic titrated cardiac injury caused by radiofrequency catheter ablation of atrial fibrillation mobilizes CD34-positive mononuclear cells by non-stromal cell-derived factor-1 mechanism. Europace 11:8, 1024-1031
CrossRef152
A. Bortone, S. Boveda, J.-L. Pasquie, P. Pujadas-Berthault, E. Marijon, A. Appetiti, J.-P. Albenque. (2009) Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication. Europace 11:8, 1018-1023
CrossRef153
DAVID E. DAWE, VIGNENDRA ARIYARAJAH, ALIASGHAR KHADEM. (2009) Is There a Role for Statins in Atrial Fibrillation?. Pacing and Clinical Electrophysiology 32:8, 1063-1072
CrossRef154
David J. Wilber. (2009) Pursuing Sinus Rhythm in Patients With Persistent Atrial Fibrillation. Journal of the American College of Cardiology 54:9, 796-798
CrossRef155
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, C. W. Israel, K.-H. Kuck, G. Y.H. Lip, S. Nattel, R. L. Page, U. Ravens, U. Schotten, G. Steinbeck, P. Vardas, A. Waldo, K. Wegscheider, S. Willems, G. Breithardt. (2009) Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Europace 11:7, 860-885
CrossRef156
Nikolaos Dagres, Christos Varounis, Panayota Flevari, Christopher Piorkowski, Kerstin Bode, Loukianos S. Rallidis, Elias Tsougos, Dionyssios Leftheriotis, Philipp Sommer, Gerhard Hindricks, Dimitrios Th. Kremastinos. (2009) Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials. American Heart Journal 158:1, 15-20
CrossRef157
MAURICIO ARRUDA. (2009) As Far As We Know…“AF Triggers Are the Culprit of PAF and Its Ablation Failure”. Journal of Cardiovascular Electrophysiology 20:7, 723-725
CrossRef158
C. Jons, P. S. Hansen, A. Johannessen, G. Hindricks, P. Raatikainen, O. Kongstad, H. Walfridsson, S. Pehrson, H. Almroth, J. Hartikainen, A. K. Petersen, L. S. Mortensen, J. C. Nielsen, . (2009) The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation. Europace 11:7, 917-923
CrossRef159
Dimpi Patel, Andrea Natale, Luigi Di Biase, J David Burkhardt, Yan Wang, Javier E Sanchez, Rodney P Horton, Mohammed Khan. (2009) Catheter ablation for atrial fibrillation: a promising therapy for congestive heart failure. Expert Review of Cardiovascular Therapy 7:7, 779-787
CrossRef160
JONG-IL CHOI, HUI-NAM PAK, JAE HYUNG PARK, EUN JEONG CHOI, SOOK KYOUNG KIM, JAE JIN KWAK, JIN KUN JANG, CHUN HWANG, YOUNG-HOON KIM. (2009) Clinical Significance of Complete Conduction Block of the Left Lateral Isthmus and Its Relationship with Anatomical Variation of the Vein of Marshall in Patients with Nonparoxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 20:6, 616-622
CrossRef161
Bernard Belhassen. (2009) A 1 Per 1,000 Mortality Rate After Catheter Ablation of Atrial Fibrillation. Journal of the American College of Cardiology 53:19, 1804-1806
CrossRef162
LAURENT ROTEN, STEFANO F. RIMOLDI, NICOLA SCHWICK, TAKAO SAKATA, CHRIS HEIMGARTNER, JUERG FUHRER, ETIENNE DELACRÉTAZ, HILDEGARD TANNER. (2009) Gender Differences in Patients Referred for Atrial Fibrillation Management to a Tertiary Center. Pacing and Clinical Electrophysiology 32:5, 622-626
CrossRef163
Mark Henein, Avin Calcuttea, Agnes Kaba, Dejan Maras, Marilyn Stanton, Mary Kelly, El-Sadig Kazzam, Anders Waldenstrom, Michael Y. Henein. (2009) Atrial fibrillation (mechanistic view point). International Journal of Cardiology 134:2, 270-272
CrossRef164
A. John Camm, Irina Savelieva. (2009) Atrial Fibrillation: A4 study: proof of concept?. Nature Reviews Cardiology 6:5, 332-334
CrossRef165
M. D. O'Neill, M. Wright, S. Knecht, P. Jais, M. Hocini, Y. Takahashi, A. Jonsson, F. Sacher, S. Matsuo, K. T. Lim, L. Arantes, N. Derval, N. Lellouche, I. Nault, P. Bordachar, J. Clementy, M. Haissaguerre. (2009) Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. European Heart Journal 30:9, 1105-1112
CrossRef166
Alex V. Postma, Lukas R.C. Dekker, Alexandre T. Soufan, Antoon F.M. Moorman. (2009) Developmental and Genetic Aspects of Atrial Fibrillation. Trends in Cardiovascular Medicine 19:4, 123-130
CrossRef167
Louise Bagge, Per Blomström, Leif Nilsson, Gunnar Myrdal Einarsson, Lena Jidéus, Carina Blomström-Lundqvist. (2009) Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery 137:5, 1265-1271
CrossRef168
Adam S. Helms, J. Jason West, Amit Patel, Michael J. Lipinski, J. Michael Mangrum, J. Paul Mounsey, John P. DiMarco, John D. Ferguson. (2009) Relation of Left Atrial Volume from Three-Dimensional Computed Tomography to Atrial Fibrillation Recurrence Following Ablation. The American Journal of Cardiology 103:7, 989-993
CrossRef169
Li-Wei Lo, Ching-Tai Tai, Yenn-Jiang Lin, Shih-Lin Chang, Ameya R. Udyavar, Yu-Feng Hu, Kuo-Chang Ueng, Wen-Chin Tsai, Ta-Chun Tuan, Chien-Jung Chang, Tsair Kao, Hsuan-Ming Tsao, Wanwarang Wongcharoen, Satoshi Higa, Shih-Ann Chen. (2009) Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: Implications for catheter ablation strategy and long-term outcome. Heart Rhythm 6:3, 311-318
CrossRef170
JAE H. PARK, HUI-NAM PAK, SOOK K. KIM, JIN K. JANG, JONG I. CHOI, HONG E. LIM, CHUN HWANG, YOUNG-HOON KIM. (2009) Electrophysiologic Characteristics of Complex Fractionated Atrial Electrograms in Patients with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 20:3, 266-272
CrossRef171
MILOS KESEK, TITTI TOLLEFSEN, NIKLAS HÖGLUND, FOLKE RÖNN, ULF NÄSLUND, STEEN M. JENSEN. (2009) U22, a Protocol to Quantify Symptoms Associated with Supraventricular Tachycardia. Pacing and Clinical Electrophysiology 32, S105-S108
CrossRef172
Anil Pandit, Nassir F. Marrouche. (2009) Cardiac Magnetic Resonance in the World of the Cardiac Electrophysiologist. JACC: Cardiovascular Imaging 2:3, 317-318
CrossRef173
Hakan Oral, Aman Chugh, Kentaro Yoshida, Jean F. Sarrazin, Michael Kuhne, Thomas Crawford, Nagib Chalfoun, Darryl Wells, Warangkna Boonyapisit, Srikar Veerareddy, Sreedhar Billakanty, Wai S. Wong, Eric Good, Krit Jongnarangsin, Frank Pelosi, Frank Bogun, Fred Morady. (2009) A Randomized Assessment of the Incremental Role of Ablation of Complex Fractionated Atrial Electrograms After Antral Pulmonary Vein Isolation for Long-Lasting Persistent Atrial Fibrillation. Journal of the American College of Cardiology 53:9, 782-789
CrossRef174
GIRISH M. NAIR, PABLO B. NERY, SYAMKUMAR DIWAKARAMENON, JEFFREY S. HEALEY, STUART J. CONNOLLY, CARLOS A. MORILLO. (2009) A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 20:2, 138-144
CrossRef175
IRENE HOF, ARMIN ARBAB-ZADEH, DANIEL SCHERR, KARUNA CHILUKURI, DARSHAN DALAL, THEODORE ABRAHAM, JOAO LIMA, HUGH CALKINS. (2009) Correlation of Left Atrial Diameter by Echocardiography and Left Atrial Volume by Computed Tomography. Journal of Cardiovascular Electrophysiology 20:2, 159-163
CrossRef176
Ana Clara Tude Rodrigues, Mauricio I. Scannavacca, Márcia Azevedo Caldas, Viviane Tiemi Hotta, Cristiano Pisani, Eduardo A. Sosa, Wilson Mathias. (2009) Left Atrial Function After Ablation for Paroxysmal Atrial Fibrillation. The American Journal of Cardiology 103:3, 395-398
CrossRef177
Ziad F. Issa, John M. Miller, Douglas P. Zipes. 2009. Atrial Fibrillation. , 208-286.
CrossRef178
Tetsuya Haruna, Shigeru Ikeguchi, Shinsaku Takeda, Naoki Amaya, Tatsuhiko Hata, Masaharu Okada, Kunihiko Kosuga. (2009) An Aggressive Strategy for Maintenance of Sinus Rhythm Including a Combination of Catheter Ablation and Antiarrhythmic Drug Therapy Benefits Patients with Chronic Atrial Fibrillation. Journal of Arrhythmia 25:2, 63-69
CrossRef179
Troy J Badger, Yaw A Adjei-Poku, Nassir F Marrouche. (2009) MRI in cardiac electrophysiology: the emerging role of delayed-enhancement MRI in atrial fibrillation ablation. Future Cardiology 5:1, 63-70
CrossRef180
Hua He, Junping Kang, Hailong Tao, Bin Zhen, Ming Zhang, Deyong Long, Jianzeng Dong. (2009) Conventional oral anticoagulation may not replace prior transesophageal echocardiography for the patients with planned catheter ablation for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 24:1, 19-26
CrossRef181
Paul G Novak. (2009) Effectiveness of catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation. Current Opinion in Cardiology 24:1, 9-17
CrossRef182
YAARIV KHAYKIN, XIAOYIN WANG, ANDREA NATALE, OUSSAMA M. WAZNI, ALLAN C. SKANES, KARIN H. HUMPHRIES, CHARLES R. KERR, ATUL VERMA, CARLOS A. MORILLO. (2009) Cost Comparison of Ablation Versus Antiarrhythmic Drugs As First-Line Therapy for Atrial Fibrillation: An Economic Evaluation of the RAAFT Pilot Study. Journal of Cardiovascular Electrophysiology 20:1, 7-12
CrossRef183
Felipe Atienza, Jesús Almendral, José Jalife, Sharon Zlochiver, Robert Ploutz-Snyder, Esteban G. Torrecilla, Ángel Arenal, Jérôme Kalifa, Francisco Fernández-Avilés, Omer Berenfeld. (2009) Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm. Heart Rhythm 6:1, 33-40
CrossRef184
Jeong-Hwan Park, Yong-Seog Oh, Ji-Hoon Kim, Woo-Baek Chung, Su-Sung Oh, Dong-Hyun Lee, Yun-Seok Choi, Woo-Seung Shin, Chul-Soo Park, Ho-Joong Youn, Wook-Sung Chung, Man-Young Lee, Ki-Bae Seung, Tae-Ho Rho, Jae-Hyung Kim, Soon-Jo Hong. (2009) Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation. Korean Circulation Journal 39:5, 185
CrossRef185
Martin Fiala, Jan Chovančík, Dorota Wojnarová, Veronika Bulková, Henryk Szymeczek, Renáta Nevřalová, Radek Neuwirth, Otakar Jiravský, Libor Škňouřil, Miloslav Dorda, Jaroslav Januška, Marian Branny. (2008) Results of complex left atrial ablation of long-lasting persistent atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 23:3, 189-198
CrossRef186
Lucas V.A. Boersma, Maurits C.E.F. Wijffels, Hakan Oral, Eric F.D. Wever, Fred Morady. (2008) Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm 5:12, 1635-1642
CrossRef187
Claude S. Elayi, Atul Verma, Luigi Di Biase, Chi Keong Ching, Dimpi Patel, Conor Barrett, David Martin, Bai Rong, Tamer S. Fahmy, Yaariv Khaykin, Richard Hongo, Steven Hao, Gemma Pelargonio, Antonio Dello Russo, Michela Casella, Pietro Santarelli, Domenico Potenza, Raffaele Fanelli, Raimondo Massaro, Mauricio Arruda, Robert A. Schweikert, Andrea Natale. (2008) Ablation for longstanding permanent atrial fibrillation: Results from a randomized study comparing three different strategies. Heart Rhythm 5:12, 1658-1664
CrossRef188
Gudrun M. Feuchtner, Wolfgang Dichtl, Tony DeFrance, Markus Stühlinger, Andrea Klauser, Thomas Berger, Daniel Junker, Karin Spuller, Otmar Pachinger, Dieter zur Nedden, Florian Hintringer. (2008) Fusion of multislice computed tomography and electroanatomical mapping data for 3D navigation of left and right atrial catheter ablation. European Journal of Radiology 68:3, 456-464
CrossRef189
DAVID R. TOMLINSON, NIKANT SABHARWAL, YAVER BASHIR, TIMOTHY R. BETTS. (2008) Interatrial Septum Thickness and Difficulty with Transseptal Puncture during Redo Catheter Ablation of Atrial Fibrillation. Pacing and Clinical Electrophysiology 31:12, 1606-1611
CrossRef190
David J. Callans. (2008) Comparison of different ablation strategies for persistent atrial fibrillation: Beyond casual observations. Heart Rhythm 5:12, 1665-1666
CrossRef191
G. Andrikopoulos, S. Tzeis, N. Maniadakis, H. E. Mavrakis, P. E. Vardas. (2008) Cost-effectiveness of atrial fibrillation catheter ablation. Europace 11:2, 147-151
CrossRef192
S. Knecht, I. Nault, M. Wright, S. Matsuo, N. Lellouche, P. E. Somasundaram, M. D. O'Neill, K.-T. Lim, F. Sacher, A. Deplagne, P. Bordachar, M. Hocini, J. Clementy, M. Haissaguerre, P. Jais. (2008) Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view. Europace 10:Supplement 3, iii2-iii7
CrossRef193
Carlo Pappone, Andrea Radinovic, Francesco Manguso, Gabriele Vicedomini, Giuseppe Ciconte, Stefania Sacchi, Patrizio Mazzone, Gabriele Paglino, Simone Gulletta, Simone Sala, Vincenzo Santinelli. (2008) Atrial fibrillation progression and management: A 5-year prospective follow-up study. Heart Rhythm 5:11, 1501-1507
CrossRef194
S. Knecht, M. Hocini, M. Wright, N. Lellouche, M. D. O'Neill, S. Matsuo, I. Nault, V. S. Chauhan, K. J. Makati, M. Bevilacqua, K.-T. Lim, F. Sacher, A. Deplagne, N. Derval, P. Bordachar, P. Jais, J. Clementy, M. Haissaguerre. (2008) Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. European Heart Journal 29:19, 2359-2366
CrossRef195
Christopher J. McGann, Eugene G. Kholmovski, Robert S. Oakes, Joshua J.E. Blauer, Marcos Daccarett, Nathan Segerson, Kelly J. Airey, Nazem Akoum, Eric Fish, Troy J. Badger, Edward V.R. DiBella, Dennis Parker, Rob S. MacLeod, Nassir F. Marrouche. (2008) New Magnetic Resonance Imaging-Based Method for Defining the Extent of Left Atrial Wall Injury After the Ablation of Atrial Fibrillation. Journal of the American College of Cardiology 52:15, 1263-1271
CrossRef196
Henry R. Halperin, Saman Nazarian. (2008) Damage Assessment After Ablation. Journal of the American College of Cardiology 52:15, 1272-1273
CrossRef197
Steven M. Markowitz. (2008) Ablation of atrial fibrillation: Patient selection, technique, and outcome. Current Cardiology Reports 10:5, 360-366
CrossRef198
JAMES M. McCABE, LISA M. SMITH, ZIAN H. TSENG, NITISH BADHWAR, BYRON K. LEE, RANDALL J. LEE, MELVIN M. SCHEINMAN, JEFFREY E. OLGIN, GREGORY M. MARCUS. (2008) Protracted CRP Elevation after Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology 31:9, 1146-1151
CrossRef199
Fabio Leonelli, Anne B. Curtis. (2008) Nonpharmacologic therapy of atrial fibrillation. Current Cardiovascular Risk Reports 2:5, 365-371
CrossRef200
S. H. Hohnloser, G. Z. Duray, U. Baber, J. L. Halperin. (2008) Prevention of stroke in patients with atrial fibrillation: current strategies and future directions. European Heart Journal Supplements 10:Suppl H, H4-H10
CrossRef201
A. J. Camm, J. A. Reiffel. (2008) Defining endpoints in clinical trials on atrial fibrillation. European Heart Journal Supplements 10:Suppl H, H55-H78
CrossRef202
Andre d'Avila, Jeremy N. Ruskin. (2008) Nonpharmacologic Strategies: The Evolving Story of Ablation and Hybrid Therapy. The American Journal of Cardiology 102:6, 20H-24H
CrossRef203
Gerald V Naccarelli, Mario D Gonzalez. (2008) Atrial Fibrillation and the Expanding Role of Catheter Ablation: Do Antiarrhythmic Drugs Have a Future?. Journal of Cardiovascular Pharmacology 52:3, 203-209
CrossRef204
E. Aliot, J. N. Ruskin. (2008) Controversies in ablation of atrial fibrillation. European Heart Journal Supplements 10:Suppl H, H32-H54
CrossRef205
Andreas Rillig, Udo Meyerfeldt, Ralf Birkemeyer, Fabian Treusch, Markus Kunze, Werner Jung. (2008) Persistent iatrogenic atrial septal defect after pulmonary vein isolation. Journal of Interventional Cardiac Electrophysiology 22:3, 177-181
CrossRef206
H. Malmborg, S. Lonnerholm, C. Blomstrom-Lundqvist. (2008) Acute and clinical effects of cryoballoon pulmonary vein isolation in patients with symptomatic paroxysmal and persistent atrial fibrillation. Europace 10:11, 1277-1280
CrossRef207
BENEDICT M. GLOVER, CONOR J. McCANN, GANESH MANOHARAN, SIMON J. WALSH, MICHAEL J. MOORE, JAMES D. ALLEN, OMAR ESCALONA, JOHN MCC. ANDERSON, TOM G. TROUTON, MIKE STEVENSON, MICHAEL J. ROBERTS, JENNIFER AA. ADGEY. (2008) A Pilot Study of a Low-Tilt Biphasic Waveform for Transvenous Cardioversion of Atrial Fibrillation: Improved Efficacy Compared with Conventional Capacitor-Based Waveforms in Patients. Pacing and Clinical Electrophysiology 31:8, 1020-1024
CrossRef208
MARTIN FIALA, JAN CHOVANČÍK, RENÁTA NEVŘALOVÁ, RADEK NEUWIRTH, OTAKAR JIRAVSKÝ, JAROSLAV JANUŠKA, MARIAN BRANNY. (2008) Termination of Long-Lasting Persistent Versus Short-Lasting Persistent and Paroxysmal Atrial Fibrillation by Ablation. Pacing and Clinical Electrophysiology 31:8, 985-997
CrossRef209
MATTHEW R. REYNOLDS, ETHAN ELLIS, PETER ZIMETBAUM. (2008) Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of Interventions. Journal of Cardiovascular Electrophysiology 19:7, 762-768
CrossRef210
Sung-Hee Shin, Mi-Young Park, Woong-Jin Oh, Soon-Jun Hong, Hui-Nam Pak, Woo-Hyuk Song, Do-Sun Lim, Young-Hoon Kim, Wan-Joo Shim. (2008) Left Atrial Volume Is a Predictor of Atrial Fibrillation Recurrence After Catheter Ablation. Journal of the American Society of Echocardiography 21:6, 697-702
CrossRef211
Arash Arya, Christopher Piorkowski, Phillip Sommer, Andreas Bollmann, Gerhard Hindricks. (2008) Ablation of atrial fibrillation. Herzschrittmachertherapie + Elektrophysiologie 19:2, 68-72
CrossRef212
Hakan Oral. (2008) What have we learned about atrial arrhythmias from ablation of chronic atrial fibrillation?. Heart Rhythm 5:6, S36-S39
CrossRef213
DAVID D. SPRAGG, DARSHAN DALAL, AAMIR CHEEMA, DANIEL SCHERR, KARUNA CHILUKURI, ALAN CHENG, CHARLES A. HENRIKSON, JOSEPH E. MARINE, RONALD D. BERGER, JUN DONG, HUGH CALKINS. (2008) Complications of Catheter Ablation for Atrial Fibrillation: Incidence and Predictors. Journal of Cardiovascular Electrophysiology 19:6, 627-631
CrossRef214
MATTHEW WRIGHT, MICHEL HAÏSSAGUERRE, SÉBASTIEN KNECHT, SEIICHIRO MATSUO, MARK D. O'NEILL, ISABELLE NAULT, NICOLAS LELLOUCHE, MÉLÈZE HOCINI, FREDERIC SACHER, PIERRE JAIS. (2008) State of the Art: Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 19:6, 583-592
CrossRef215
NICOLAS LELLOUCHE, PIERRE JAÏS, ISABELLE NAULT, MATTHEW WRIGHT, MICHELA BEVILACQUA, SÉBASTIEN KNECHT, SEIICHIRO MATSUO, KANG-TENG LIM, FREDERIC SACHER, ANTOINE DEPLAGNE, PIERRE BORDACHAR, MÉLÈZE HOCINI, MICHEL HAÏSSAGUERRE. (2008) Early Recurrences After Atrial Fibrillation Ablation: Prognostic Value and Effect of Early Reablation. Journal of Cardiovascular Electrophysiology 19:6, 599-605
CrossRef216
HUI-NAM PAK, JIN SEOK KIM, SEUNG YONG SHIN, HYUN SOO LEE, JONG IL CHOI, HONG EUY LIM, CHUN HWANG, YOUNG-HOON KIM. (2008) Is Empirical Four Pulmonary Vein Isolation Necessary for Focally Triggered Paroxysmal Atrial Fibrillation? Comparison of Selective Pulmonary Vein Isolation Versus Empirical Four Pulmonary Vein Isolation. Journal of Cardiovascular Electrophysiology 19:5, 473-479
CrossRef217
Nancy M. Allen LaPointe, Jie-Lena Sun, Sigal Kaplan, Phil d’Almada, Sana M. Al-Khatib. (2008) Rhythm Versus Rate Control in the Contemporary Management of Atrial Fibrillation In-Hospital††The views expressed in this report are those of the investigators and do not necessarily represent the views of the FDA.. The American Journal of Cardiology 101:8, 1134-1141
CrossRef218
ROBERT KENNEDY, ERIC GOOD, HAKAN ORAL, ELIZABETH HUETHER, FRANK BOGUN, FRANK PELOSI, FRED MORADY, AMAN CHUGH. (2008) Temporal Stability of the Location of the Esophagus in Patients Undergoing a Repeat Left Atrial Ablation Procedure for Atrial Fibrillation or Flutter. Journal of Cardiovascular Electrophysiology 19:4, 351-355
CrossRef219
Y-J Chen, Y-C Chen, W Wongcharoen, C-I Lin, S-A Chen. (2008) Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes. British Journal of Pharmacology 153:5, 915-925
CrossRef220
AGUSTÍN BORTONE, SERGE BOVEDA, NICOLAS COMBES, JEAN-PAUL ALBENQUE. (2008) Clockwise Loop of the Ablation Catheter in the Left Atrium: An Easy and Safe Approach Facilitating Substrate Modulation in the Setting of Atrial Fibrillation Ablation. Journal of Cardiovascular Electrophysiology 19:3, 338-341
CrossRef221
John R. Kapoor. (2008) Atrial Fibrillation Ablation: Is There Any Good Evidence Behind It?. The American Journal of Medicine 121:3, e9
CrossRef222
Irina Savelieva, John Camm. (2008) Update on atrial fibrillation: Part II. Clinical Cardiology 31:3, 102-108
CrossRef223
Heidi L. Estner, Gabriele Hessling, Gjin Ndrepepa, Armin Luik, Claus Schmitt, Agathe Konietzko, Ekrem Ücer, JinJin Wu, Christof Kolb, Andreas Pflaumer, Bernhard Zrenner, Isabel Deisenhofer. (2008) Acute Effects and Long-Term Outcome of Pulmonary Vein Isolation in Combination With Electrogram-Guided Substrate Ablation for Persistent Atrial Fibrillation. The American Journal of Cardiology 101:3, 332-337
CrossRef224
Koonlawee Nademanee, Mark C. Schwab, Erol M. Kosar, Margaret Karwecki, Michael D. Moran, Nithi Visessook, Anthony Don Michael, Tachapong Ngarmukos. (2008) Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation. Journal of the American College of Cardiology 51:8, 843-849
CrossRef225
Atul Verma. (2008) Atrial-fibrillation ablation should be considered first-line therapy for some patients. Current Opinion in Cardiology 23:1, 1-8
CrossRef226
Thomas C. Crawford, Alan Wimmer, Sujoya Dey, Nagib Chalfoun, Darryl Wells, Jean-Francois Sarrazin, Michael Kuhne, Melissa Frederick, Krit Jongnarangsin, Eric Good, Aman Chugh, Frank Bogun, Frank Pelosi, Fred Morady, Hakan Oral. (2008) Mechanism of recurrence after radiofrequency catheter ablation of atrial fibrillation guided by complex fractionated atrial electrograms. Journal of Interventional Cardiac Electrophysiology 21:1, 27-33
CrossRef227
J. Jason West, Patrick T. Norton, Christopher M. Kramer, J. Randall Moorman, Srijoy Mahapatra, John P. DiMarco, J. Michael Mangrum, J. Paul Mounsey, John D. Ferguson. (2008) Characterization of the mitral isthmus for atrial fibrillation ablation using intracardiac ultrasound from within the coronary sinus. Heart Rhythm 5:1, 19-27
CrossRef228
Jong-Il Choi, Seong Mi Park, Jae Seok Park, Soon Jun Hong, Hui-Nam Pak, Do Sun Lim, Young-Hoon Kim, Wan Joo Shim. (2008) Changes in Left Atrial Structure and Function After Catheter Ablation and Electrical Cardioversion for Atrial Fibrillation. Circulation Journal 72:12, 2051-2057
CrossRef229
Thomas D. Callahan, Andrea Natale. (2008) Catheter Ablation of Atrial Fibrillation. Medical Clinics of North America 92:1, 179-201
CrossRef230
Knut Gjesdal, Gunn E Vist, Einar Bugge, Ole Rossvoll, Marit Johansen, Inger Norderhaug, Ole-J Ohm. (2008) Curative ablation for atrial fibrillation: A systematic review. Scandinavian Cardiovascular Journal 42:1, 3-8
CrossRef231
Antonio Rossillo, Aldo Bonso, Sakis Themistoclakis, Giuseppe Riccio, Michela Madalosso, Andrea Corrado, Bruno De Piccoli, Antonio Raviele. (2008) Role of anticoagulation therapy after pulmonary vein antrum isolation for atrial fibrillation treatment. Journal of Cardiovascular Medicine 9:1, 51-55
CrossRef232
Paulus Kirchhof, Andreas Goette, Gerd Hindricks, Stefan Hohnloser, Karl-Heinz Kuck, Thomas Meinertz, Ursula Ravens, Gerhard Steinbeck, Günter Breithardt. (2007) Endpunkte für Studien bei Patienten mit Vorhofflimmern. Herzschrittmachertherapie & Elektrophysiologie 18:4, 259-268
CrossRef233
Y. Blaauw, H. J. G. M. Crijns. (2007) Atrial fibrillation: insights from clinical trials and novel treatment options. Journal of Internal Medicine 262:6, 593-614
CrossRef234
Mark A. Groh, Oliver A. Binns, Harry G. Burton, Stephen W. Ely, Alan M. Johnson. (2007) Ultrasonic Cardiac Ablation for Atrial Fibrillation During Concomitant Cardiac Surgery: Long-Term Clinical Outcomes. The Annals of Thoracic Surgery 84:6, 1978-1983
CrossRef235
Richard B. Schuessler, Ralph J. Damiano. (2007) Mechanisms of human atrial fibrillation: Lessons learned from 20 years of atrial fibrillation surgery. Journal of Interventional Cardiac Electrophysiology 20:3, 59-64
CrossRef236
A. Marc Gillinov. (2007) Choice of Surgical Lesion Set: Answers From the Data. The Annals of Thoracic Surgery 84:5, 1786-1792
CrossRef237
SÉBASTIEN KNECHT, MARK D. O'NEILL, SEIICHIRO MATSUO, KANG-TENG LIM, LEONARDO ARANTES, NICOLAS DERVAL, GEORGES J. KLEIN, MÉLÈZE HOCINI, PIERRE JAÏS, JACQUES CLÉMENTY, MICHEL HAÏSSAGUERRE. (2007) Focal Arrhythmia Confined Within the Coronary Sinus and Maintaining Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 18:11, 1140-1146
CrossRef238
Carlo Pappone, Giuseppe Augello, Filippo Gugliotta, Vincenzo Santinelli. (2007) Robotic and magnetic navigation for atrial fibrillation ablation. How and why?. Expert Review of Medical Devices 4:6, 885-894
CrossRef239
Carmelo Lafuente-Lafuente, Stephane Mouly, Miguel Angel Longas-Tejero, Jean-François Bergmann, Carmelo Lafuente-Lafuente. 2007. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. .
CrossRef240
Richard Kobza, Christoph Auf der Maur, Claudia Kurtz, Alexander Hoffmann, Bernhard Allgayer, Paul Erne. (2007) Esophagus imaging for radiofrequency ablation of atrial fibrillation using a dual-source computed tomography system: Preliminary observations. Journal of Interventional Cardiac Electrophysiology 19:3, 167-170
CrossRef241
Emanuele Bertaglia, Franco Zoppo, Claudio Tondo, Andrea Colella, Roberto Mantovan, Gaetano Senatore, Nicola Bottoni, Giovanni Carreras, Leonardo Corò, Pietro Turco, Massimo Mantica, Giuseppe Stabile. (2007) Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety. Heart Rhythm 4:10, 1265-1271
CrossRef242
Mathew Hutchinson, David J. Callans. (2007) Assessing the complications from atrial fibrillation ablation: Closer to truth. Heart Rhythm 4:10, 1272-1273
CrossRef243
Sanders Chae, Hakan Oral, Eric Good, Sujoya Dey, Alan Wimmer, Thomas Crawford, Darryl Wells, Jean-Francois Sarrazin, Nagib Chalfoun, Michael Kuhne, Jackie Fortino, Elizabeth Huether, Tammy Lemerand, Frank Pelosi, Frank Bogun, Fred Morady, Aman Chugh. (2007) Atrial Tachycardia After Circumferential Pulmonary Vein Ablation of Atrial Fibrillation. Journal of the American College of Cardiology 50:18, 1781-1787
CrossRef244
Eric W. Schneeberger, Robert M. Osterday. (2007) Lateral Placement of Bipolar Clamp Facilitates Pulmonary Vein Isolation. The Annals of Thoracic Surgery 84:4, 1412-1413
CrossRef245
Omer Berenfeld. (2007) Quantifying activation frequency in atrial fibrillation to establish underlying mechanisms and ablation guidance. Heart Rhythm 4:9, 1225-1234
CrossRef246
Richard B. Schuessler, Ralph J. Damiano. (2007) Patient-specific surgical strategy for atrial fibrillation: Promises and challenges. Heart Rhythm 4:9, 1222-1224
CrossRef247
Takumi Yamada, G. Neal Kay. (2007) Evidence-based approach to ablating atrial fibrillation. Current Cardiology Reports 9:5, 366-370
CrossRef248
DIPEN C. SHAH, HENRI SUNTHORN, HARAN BURRI, PASCALE GENTIL-BARON. (2007) Evaluation of an Individualized Strategy of Cavotricuspid Isthmus Ablation as an Adjunct to Atrial Fibrillation Ablation. Journal of Cardiovascular Electrophysiology 18:9, 926-930
CrossRef249
YAARIV KHAYKIN, CARLOS A. MORILLO, ALLAN C. SKANES, AARON MCCRACKEN, KARIN HUMPHRIES, CHARLES R. KERR. (2007) Cost Comparison of Catheter Ablation and Medical Therapy in Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 18:9, 907-913
CrossRef250
Rudolph F. Evonich, David M. Nori, David E. Haines. (2007) A randomized trial comparing effects of radiofrequency and cryoablation on the structural integrity of esophageal tissue. Journal of Interventional Cardiac Electrophysiology 19:2, 77-83
CrossRef251
Hans Kottkamp, Gerd Hindricks. (2007) Complex fractionated atrial electrograms in atrial fibrillation: A promising target for ablation, but why, when, and how?. Heart Rhythm 4:8, 1021-1023
CrossRef252
MARTIN MARTINEK, JOSEF AICHINGER, HANS-JOACHIM NESSER, PAUL D. ZIEGLER, HELMUT PURERFELLNER. (2007) New Insights into Long-Term Follow-Up of Atrial Fibrillation Ablation: Full Disclosure by an Implantable Pacemaker Device. Journal of Cardiovascular Electrophysiology 18:8, 818-823
CrossRef253
André d’Avila, Aravinda Thiagalingam. (2007) Spot cryoablation: A cool new way to achieve pulmonary vein isolation. Heart Rhythm 4:8, 997-998
CrossRef254
Fred Morady. (2007) Patient-specific ablation strategy for atrial fibrillation: Promises and difficulties. Heart Rhythm 4:8, 1094-1096
CrossRef255
Emile G Daoud. (2007) Percutaneous catheter ablation of atrial fibrillation. Expert Review of Cardiovascular Therapy 5:4, 693-705
CrossRef256
Aman Chugh. (2007) Catheter ablation as first-line therapy for patients with symptomatic atrial fibrillation. Expert Review of Cardiovascular Therapy 5:4, 663-672
CrossRef257
B.-D. Gonska. (2007) Stellenwert der Katheterablation bei paroxysmalem und persistierendem/permanentem Vorhofflimmern. Clinical Research in Cardiology Supplements 2:4, IV64-IV70
CrossRef258
Sébastien Bonnet, Stephen L. Archer. (2007) Potassium channel diversity in the pulmonary arteries and pulmonary veins: Implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension. Pharmacology & Therapeutics 115:1, 56-69
CrossRef259
Karl Mischke, Thomas Schimpf, Christian Knackstedt, Peter Hanrath, Patrick Schauerte. (2007) Single-step atrial thrombus exclusion and transesophageal cardioversion in atrial fibrillation. Expert Review of Medical Devices 4:4, 549-557
CrossRef260
Stuart P. Thomas. (2007) Operative and Percutaneous Procedures for Cure of Atrial Fibrillation. Heart, Lung and Circulation 16:3, 229-233
CrossRef261
NASSIR F. MARROUCHE, JENS GUENTHER, NATHAN M SEGERSON, MARCOS DACCARETT, HARALD RITTGER, HARALD MARSCHANG, VOLKER SCHIBGILLA, MARTIN SCHMIDT, GUIDO RITSCHER, GEORG NOELKER, JOHANNES BRACHMANN. (2007) Randomized Comparison Between Open Irrigation Technology and Intracardiac-Echo-Guided Energy Delivery for Pulmonary Vein Antrum Isolation: Procedural Parameters, Outcomes, and the Effect on Esophageal Injury. Journal of Cardiovascular Electrophysiology 18:6, 583-588
CrossRef262
Margaret C. Fang, Jane Chen, Michael W. Rich. (2007) Atrial Fibrillation in the Elderly. The American Journal of Medicine 120:6, 481-487
CrossRef263
MATTHEW R. REYNOLDS, VIDAL ESSEBAG, PETER ZIMETBAUM, DAVID J. COHEN. (2007) Healthcare Resource Utilization and Costs Associated with Recurrent Episodes of Atrial Fibrillation: The FRACTAL Registry. Journal of Cardiovascular Electrophysiology 18:6, 628-633
CrossRef264
Hugh Calkins, Josep Brugada, Douglas L. Packer, Riccardo Cappato, Shih-Ann Chen, Harry J.G. Crijns, Ralph J. Damiano, D. Wyn Davies, David E. Haines, Michel Haissaguerre, Yoshito Iesaka, Warren Jackman, Pierre Jais, Hans Kottkamp, Karl Heinz Kuck, Bruce D. Lindsay, Francis E. Marchlinski, Patrick M. McCarthy, J. Lluis Mont, Fred Morady, Koonlawee Nademanee, Andrea Natale, Carlo Pappone, Eric Prystowsky, Antonio Raviele, Jeremy N. Ruskin, Richard J. Shemin. (2007) HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up. Heart Rhythm 4:6, 816-861
CrossRef265
Mark E. Josephson. (2007) Electrophysiology at a crossroads. Heart Rhythm 4:5, 658-661
CrossRef266
George J. Klein. (2007) Electrophysiology at crossroads: A time of great opportunity. Heart Rhythm 4:5, 662-664
CrossRef267
Hakan Oral. (2007) Catheter ablation for chronic atrial fibrillation. Heart Rhythm 4:5, 691-694
CrossRef268
ANDREA NATALE, ANTONIO RAVIELE, THOMAS ARENTZ, HUGH CALKINS, SHIH-ANN CHEN, MICHEL HAÏSSAGUERRE, GERHARD HINDRICKS, YEN HO, KARL HEINZ KUCK, FRANCIS MARCHLINSKI, CARLO NAPOLITANO, DOUGLAS PACKER, CARLO PAPPONE, ERIC N. PRYSTOWSKY, RICHARD SCHILLING, DIPEN SHAH, SAKIS THEMISTOCLAKIS, ATUL VERMA. (2007) Venice Chart International Consensus Document on Atrial Fibrillation Ablation. Journal of Cardiovascular Electrophysiology 18:5, 560-580
CrossRef269
Carlo Pappone, Vincenzo Santinelli. (2007) Mapping and ablation: A worldwide perspective. Journal of Interventional Cardiac Electrophysiology 17:3, 195-198
CrossRef270
Massimo Santini, Renato P. Ricci. (2007) The worldwide social burden of atrial fibrillation: What should be done and where do we go?. Journal of Interventional Cardiac Electrophysiology 17:3, 183-188
CrossRef271
Burr Hall, Vinodh Jeevanantham, Rochelle Simon, John Filippone, Gabriel Vorobiof, James Daubert. (2007) Variation in left atrial transmural wall thickness at sites commonly targeted for ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 17:2, 127-132
CrossRef272
Lars Grosse-Wortmann, Abdulmajeed Al-Otay, Hyun Woo Goo, Christopher K. Macgowan, John G. Coles, Leland N. Benson, Andrew N. Redington, Shi-Joon Yoo. (2007) Anatomical and Functional Evaluation of Pulmonary Veins in Children by Magnetic Resonance Imaging. Journal of the American College of Cardiology 49:9, 993-1002
CrossRef273
Hakan Oral. (2007) Catheter ablation for chronic atrial fibrillation. Heart Rhythm 4:3, e1-e4
CrossRef274
Yoshihide Takahashi, Mark D. O’Neill, Méléze Hocini, Patricia Reant, Anders Jonsson, Pierre Jaïs, Prashanthan Sanders, Thomas Rostock, Martin Rotter, Frédéric Sacher, Stephane Laffite, Raymond Roudaut, Jacques Clémenty, Michel Haïssaguerre. (2007) Effects of Stepwise Ablation of Chronic Atrial Fibrillation on Atrial Electrical and Mechanical Properties. Journal of the American College of Cardiology 49:12, 1306-1314
CrossRef275
T. JARED BUNCH, JOHN D. DAY. (2007) Unraveling the Mysteries of Catheter Ablation for Atrial Fibrillation: From Clinical Observations to Mechanistic Explorations. Journal of Cardiovascular Electrophysiology 18:3, 266-268
CrossRef276
Kristen K Patton, Richard L Page. (2007) Pharmacological therapy of atrial fibrillation. Expert Opinion on Investigational Drugs 16:2, 169-179
CrossRef277
Patrick Ruchat, Lam Dang, Nathalie Virag, Jürg Schlaepfer, Ludwig Karl von Segesser, Lukas Kappenberger. (2007) A biophysical model of atrial fibrillation to define the appropriate ablation pattern in modified maze. European Journal of Cardio-Thoracic Surgery 31:1, 65-69
CrossRef278
Brian Olshansky. (2007) Placebo and Nocebo in Cardiovascular Health. Journal of the American College of Cardiology 49:4, 415-421
CrossRef279
Yi-Jen Chen, Shih-Ann Chen. (2007) Thoracic Vein Arrhythmias. Circulation Journal 71:SupplementA, A20-A25
CrossRef280
Yaariv Khaykin. (2007) Cost-effectiveness of catheter ablation for atrial fibrillation. Current Opinion in Cardiology 22:1, 11-17
CrossRef281
CARLO PAPPONE, VINCENZO SANTINELLI. (2007) Remote Navigation and Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 18:s1, S18-S20
CrossRef282
PIETRO TURCO, ANTONIO DE SIMONE, VINCENZO LA ROCCA, ASSUNTA IULIANO, VINCENZO CAPUANO, COSTANTINO ASTARITA, TOMMASO DI NAPOLI, VINCENZO MESSINA, SILVANO BALDI, GIUSEPPE STABILE. (2007) Antiarrhythmic Drug Therapy after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation. Pacing and Clinical Electrophysiology 30:s1,
CrossRef283
EDWARD P. GERSTENFELD, DAVID CALLANS, SANJAY DIXIT, DAVID LIN, JOSHUA COOPER, ANDREA M RUSSO, RALPH VERDINO, MARK WEINER, ERICA ZADO, FRANCIS E. MARCHLINSKI. (2007) Characteristics of Patients Undergoing Atrial Fibrillation Ablation: Trends Over a Seven-Year Period 1999?2005. Journal of Cardiovascular Electrophysiology 18:1, 23-28
CrossRef284
Hugh Calkins. (2007) Catheter ablation should not be first-line therapy for atrial fibrillation. Nature Clinical Practice Cardiovascular Medicine 4:1, 4-5
CrossRef285
W.H. Frishman. (2007) Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation. Yearbook of Medicine 2007, 378-380
CrossRef286
Yoshito Iesaka, Kiyoshi Otomo, Yasutoshi Nagata, Kikuya Uno. (2007) Catheter Ablation Therapy for Atrial Fibrillation. Circulation Journal 71:SupplementA, A82-A89
CrossRef287
A.L. Waldo. (2007) Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation. Yearbook of Cardiology 2007, 429-430
CrossRef288
Shinsuke Miyazaki, Taishi Kuwahara, Atsushi Takahashi, Atsushi Kobori, Yoshihide Takahashi, Toshihiro Nozato, Hiroyuki Hikita, Akira Sato, Kazutaka Aonuma, Kenzo Hirao, Mitsuaki Isobe. (2007) Effect of Left Atrial Ablation on the Quality of Life in Patients With Atrial Fibrillation. Circulation Journal 72:4, 582-587
CrossRef289
Arcadi García-Alberola, José L. Merino. (2007) Arritmias y electrofisiología cardiaca. Revista Española de Cardiología 60, 33-40
CrossRef290
GREGORY M. MARCUS, XIUSHUI REN, ZIAN H. TSENG, NITISH BADHWAR, BYRON K. LEE, RANDALL J. LEE, ELYSE FOSTER, JEFFREY E. OLGIN. (2007) Repeat Transseptal Catheterization After Ablation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 18:1, 55-59
CrossRef291
Carlo Pappone, Giuseppe Augello, Simone Sala, Filippo Gugliotta, Gabriele Vicedomini, Simone Gulletta, Gabriele Paglino, Patrizio Mazzone, Nicoleta Sora, Isabelle Greiss, Andreina Santagostino, Laura LiVolsi, Nicola Pappone, Andrea Radinovic, Francesco Manguso, Vincenzo Santinelli. (2006) A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation. Journal of the American College of Cardiology 48:11, 2340-2347
CrossRef292
Axel Bauer, Isabel Deisenhofer, Raphael Schneider, Bernhard Zrenner, Petra Barthel, Martin Karch, Stefan Wagenpfeil, Claus Schmitt, Georg Schmidt. (2006) Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function. Heart Rhythm 3:12, 1428-1435
CrossRef293
(2006) ACC/AHA/ESC: Guías de Práctica Clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida. Revista Española de Cardiología 59:12, 1329.e1-1329.e64
CrossRef294
JEFFREY J. GOLDBERGER. (2006) Atrial Fibrillation Ablation: Location, Location, Location. Journal of Cardiovascular Electrophysiology 17:12, 1271-1273
CrossRef295
Aman Chugh, Fred Morady. (2006) Atrial fibrillation: Catheter ablation. Journal of Interventional Cardiac Electrophysiology 16:1, 15-26
CrossRef296
E. Kevin Heist, Marwan Refaat, Stephan B. Danik, Godtfred Holmvang, Jeremy N. Ruskin, Moussa Mansour. (2006) Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm 3:11, 1313-1318
CrossRef297
Stéphane Ederhy, Ariel Cohen. (2006) Optimising stroke prevention in non-valvular atrial fibrillation. Expert Opinion on Pharmacotherapy 7:15, 2079-2094
CrossRef298
Valentin Fuster, Lars E. Rydén, David S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey, G. Neal Kay, James E. Lowe, S. Bertil Olsson, Eric N. Prystowsky, Juan Luis Tamargo, Samuel Wann. (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. Journal of the American College of Cardiology 48:4, e149-e246
CrossRef299
Valentin Fuster, Lars E. Rydén, David S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey, G. Neal Kay, James E. Lowe, S. Bertil Olsson, Eric N. Prystowsky, Juan Luis Tamargo, Samuel Wann. (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary. Journal of the American College of Cardiology 48:4, 854-906
CrossRef300
Arthur J. Moss. (2006) Atrial Electrical Activity and Atrial Fibrillation. Annals of Noninvasive Electrocardiology 11:3, 201-202
CrossRef301
S. Zellerhoff, A. Goette, P. Kirchhof. (2006) Antikoagulation bei Vorhofflimmern. Herzschrittmachertherapie & Elektrophysiologie 17:2, 89-94
CrossRef302
U. Ravens, E. Wettwer, U. Schotten, R. Weßel, D. Dobrev. (2006) Neue Antiarrhythmika in der Therapie des Vorhofflimmerns. Herzschrittmachertherapie & Elektrophysiologie 17:2, 64-72
CrossRef303
Lee A. Biblo, Johan Aasbo. (2006) To catch a moving target. Heart Rhythm 3:6, 638-639
CrossRef304
Oscar Bernal, Concepción Moro. (2006) Arritmias cardiacas en la mujer. Revista Española de Cardiología 59:6, 609-618
CrossRef305
(2006) Circumferential Pulmonary-Vein Ablation for Atrial Fibrillation. New England Journal of Medicine 354:21, 2289-2291
Full Text306
Hakan Oral, Fred Morady. (2006) How to select patients for atrial fibrillation ablation. Heart Rhythm 3:5, 615-618
CrossRef307
Wood, Mark A., Ellenbogen, Kenneth A., . (2006) Catheter Ablation of Chronic Atrial Fibrillation — The Gap between Promise and Practice. New England Journal of Medicine 354:9, 967-969
Full Text
- Letters
